Thomas J. Montine, MD PhD - Publications

Affiliations: 
Pathology University of Washington, Seattle, Seattle, WA 

391 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Nelson PT, Brayne C, Flanagan ME, Abner EL, Agrawal S, Attems J, Castellani RJ, Corrada MM, Cykowski MD, Di J, Dickson DW, Dugger BN, Ervin JF, Fleming J, Graff-Radford J, ... ... Montine TJ, et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathologica. PMID 35697880 DOI: 10.1007/s00401-022-02444-1  0.771
2022 Lucot KL, Stevens MY, Bonham TA, Azevedo EC, Chaney AM, Webber ED, Jain P, Klockow JL, Jackson IM, Carlson ML, Graves EE, Montine TJ, James ML. TRACKING INNATE IMMUNE ACTIVATION IN A MOUSE MODEL OF PARKINSON'S DISEASE USING TREM1 AND TSPO PET TRACERS. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35177426 DOI: 10.2967/jnumed.121.263039  0.779
2022 Meijer M, Agirre E, Kabbe M, van Tuijn CA, Heskol A, Zheng C, Mendanha Falcão A, Bartosovic M, Kirby L, Calini D, Johnson MR, Corces MR, Montine TJ, Chen X, Chang HY, et al. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility. Neuron. PMID 35093191 DOI: 10.1016/j.neuron.2021.12.034  0.346
2021 Phongpreecha T, Gajera CR, Liu CC, Vijayaragavan K, Chang AL, Becker M, Fallahzadeh R, Fernandez R, Postupna N, Sherfield E, Tebaykin D, Latimer C, Shively CA, Register TC, Craft S, ... ... Montine TJ, et al. Single-synapse analyses of Alzheimer's disease implicate pathologic tau, DJ1, CD47, and ApoE. Science Advances. 7: eabk0473. PMID 34910503 DOI: 10.1126/sciadv.abk0473  0.8
2021 Hubbard EE, Heil LR, Merrihew GE, Chhatwal JP, Farlow MR, McLean CA, Ghetti B, Newell KL, Frosch MP, Bateman RJ, Larson EB, Keene CD, Perrin RJ, Montine TJ, MacCoss MJ, et al. Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer's Disease. Journal of Proteome Research. PMID 34818016 DOI: 10.1021/acs.jproteome.1c00558  0.3
2021 Farrell K, Kim S, Han N, Iida MA, Gonzalez EM, Otero-Garcia M, Walker JM, Richardson TE, Renton AE, Andrews SJ, Fulton-Howard B, Humphrey J, Vialle RA, Bowles KR, de Paiva Lopes K, ... ... Montine TJ, et al. Genome-wide association study and functional validation implicates JADE1 in tauopathy. Acta Neuropathologica. PMID 34719765 DOI: 10.1007/s00401-021-02379-z  0.706
2021 Wang X, Zhou X, Uberseder B, Lee J, Latimer CS, Furdui CM, Keene CD, Montine TJ, Register TC, Craft S, Shively CA, Ma T. Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease. Neurobiology of Disease. 105463. PMID 34363967 DOI: 10.1016/j.nbd.2021.105463  0.318
2021 Hong Z, Tian C, Stewart T, Aro P, Soltys D, Bercow M, Sheng L, Borden K, Khrisat T, Pan C, Zabetian CP, Peskind ER, Quinn JF, Montine TJ, Aasly J, et al. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular Vesicles. Neurology. 96: e2332-e2345. PMID 34032594 DOI: 10.1212/WNL.0000000000011853  0.778
2021 Ryman SG, Yutsis M, Tian L, Henderson VW, Montine TJ, Salmon DP, Galasko D, Poston KL. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology. Journal of Alzheimer's Disease : Jad. PMID 33646154 DOI: 10.3233/JAD-201187  0.303
2021 Latimer CS, Lucot KL, Keene CD, Cholerton B, Montine TJ. Genetic Insights into Alzheimer's Disease. Annual Review of Pathology. 16: 351-376. PMID 33497263 DOI: 10.1146/annurev-pathmechdis-012419-032551  0.821
2021 Wawro AM, Gajera CR, Baker SA, Nirschl JJ, Vogel H, Montine TJ. Creatine transport and pathological changes in creatine transporter deficient mice. Journal of Inherited Metabolic Disease. PMID 33389772 DOI: 10.1002/jimd.12358  0.754
2020 Phongpreecha T, Cholerton B, Mata IF, Zabetian CP, Poston KL, Aghaeepour N, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Edwards KL, Montine TJ. Multivariate prediction of dementia in Parkinson's disease. Npj Parkinson's Disease. 6: 20. PMID 34429432 DOI: 10.1038/s41531-020-00121-2  0.795
2020 Phongpreecha T, Fernandez R, Mrdjen D, Culos A, Gajera CR, Wawro AM, Stanley N, Gaudilliere B, Poston KL, Aghaeepour N, Montine TJ. Single-cell peripheral immunoprofiling of Alzheimer's and Parkinson's diseases. Science Advances. 6. PMID 33239300 DOI: 10.1126/sciadv.abd5575  0.812
2020 Corces MR, Shcherbina A, Kundu S, Gloudemans MJ, Frésard L, Granja JM, Louie BH, Eulalio T, Shams S, Bagdatli ST, Mumbach MR, Liu B, Montine KS, Greenleaf WJ, Kundaje A, ... ... Montine TJ, et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseases. Nature Genetics. PMID 33106633 DOI: 10.1038/s41588-020-00721-x  0.487
2020 Parker KR, Migliorini D, Perkey E, Yost KE, Bhaduri A, Bagga P, Haris M, Wilson NE, Liu F, Gabunia K, Scholler J, Montine TJ, Bhoj VG, Reddy R, Mohan S, et al. Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies. Cell. PMID 32961131 DOI: 10.1016/J.Cell.2020.08.022  0.454
2020 Phongpreecha T, Cholerton B, Mata IF, Zabetian CP, Poston KL, Aghaeepour N, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Edwards KL, Montine TJ. Multivariate prediction of dementia in Parkinson's disease. Npj Parkinson's Disease. 6: 20. PMID 32885039 DOI: 10.1038/S41531-020-00121-2  0.794
2020 Scharenberg SG, Poletto E, Lucot KL, Colella P, Sheikali A, Montine TJ, Porteus MH, Gomez-Ospina N. Author Correction: Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing. Nature Communications. 11: 4231. PMID 32820153 DOI: 10.1038/S41467-020-18044-0  0.755
2020 Gryc W, Roberts KA, Zabetian CP, Weintraub D, Trojanowski JQ, Quinn JF, Hiller AL, Chung KA, Poston KL, Yang L, Hu SC, Edwards KL, Montine TJ, Cholerton BA. Hallucinations and Development of Dementia in Parkinson's Disease. Journal of Parkinson's Disease. PMID 32741842 DOI: 10.3233/Jpd-202116  0.333
2020 Scharenberg SG, Poletto E, Lucot KL, Colella P, Sheikali A, Montine TJ, Porteus MH, Gomez-Ospina N. Engineering monocyte/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing. Nature Communications. 11: 3327. PMID 32620863 DOI: 10.1038/S41467-020-17148-X  0.774
2020 Rane S, Koh N, Oakley J, Caso C, Zabetian CP, Cholerton B, Montine TJ, Grabowski T. Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson's disease. Parkinsonism & Related Disorders. 76: 21-28. PMID 32559629 DOI: 10.1016/J.Parkreldis.2020.05.014  0.312
2020 Pontecorvo MJ, Keene CD, Beach TG, Montine TJ, Arora AK, Devous MD, Navitsky M, Kennedy I, Joshi AD, Lu M, Serrano GE, Sue LI, Intorcia AJ, Rose SE, Wilson A, et al. Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer's disease pathology: a clinicopathological study. Ejnmmi Research. 10: 65. PMID 32542468 DOI: 10.1186/S13550-020-00653-X  0.37
2020 Fleisher AS, Pontecorvo MJ, Devous MD, Lu M, Arora AK, Truocchio SP, Aldea P, Flitter M, Locascio T, Devine M, Siderowf A, Beach TG, Montine TJ, Serrano GE, Curtis C, et al. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. Jama Neurology. PMID 32338734 DOI: 10.1001/Jamaneurol.2020.0528  0.338
2020 Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, et al. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nature Medicine. PMID 32284590 DOI: 10.1038/S41591-020-0815-6  0.445
2020 Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, Quinn JF, Zabetian CP, Tian L, Longo FM, Cholerton B, ... Montine TJ, et al. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau. Brain : a Journal of Neurology. PMID 32065223 DOI: 10.1093/Brain/Awaa021  0.435
2020 Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Caselli RJ, Chen Y, Su Y, Myers AJ, Hardy J, Paul Vonsattel J, Younkin SG, Bennett DA, De Jager PL, Larson EB, ... ... Montine TJ, et al. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nature Communications. 11: 667. PMID 32015339 DOI: 10.1038/S41467-019-14279-8  0.421
2020 Cholerton B, Poston KL, Tian L, Quinn JF, Chung KA, Hiller AL, Hu SC, Specketer K, Montine TJ, Edwards KL, Zabetian CP. Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's Disease. Movement Disorders Clinical Practice. 7: 61-69. PMID 31970213 DOI: 10.1002/Mdc3.12870  0.329
2019 Morris R, Martini DN, Smulders K, Kelly VE, Zabetian CP, Poston K, Hiller A, Chung KA, Yang L, Hu SC, Edwards KL, Cholerton B, Grabowski TJ, Montine TJ, Quinn JF, et al. Cognitive associations with comprehensive gait and static balance measures in Parkinson's disease. Parkinsonism & Related Disorders. 69: 104-110. PMID 31731260 DOI: 10.1016/J.Parkreldis.2019.06.014  0.317
2019 Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, et al. Sex differences in the genetic predictors of Alzheimer's pathology. Brain : a Journal of Neurology. 142: 2581-2589. PMID 31497858 DOI: 10.1093/Brain/Awz206  0.372
2019 Higginbotham L, Dammer EB, Duong DM, Modeste E, Montine TJ, Lah JJ, Levey AI, Seyfried NT. Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer's Disease. Proteomes. 7. PMID 31461916 DOI: 10.3390/Proteomes7030030  0.353
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Montine TJ, et al. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. PMID 31417202 DOI: 10.1038/s41588-019-0495-7  0.608
2019 Mrdjen D, Fox EJ, Bukhari SA, Montine KS, Bendall SC, Montine TJ. The basis of cellular and regional vulnerability in Alzheimer's disease. Acta Neuropathologica. PMID 31392412 DOI: 10.1007/S00401-019-02054-4  0.397
2019 Ehlenbach WJ, Sonnen JA, Montine TJ, Larson EB. Association Between Sepsis and Microvascular Brain Injury. Critical Care Medicine. PMID 31389836 DOI: 10.1097/Ccm.0000000000003924  0.608
2019 Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Fardo DW, Flanagan ME, Halliday G, Hunter S, ... ... Montine TJ, et al. Reply: LATE to the PART-y. Brain : a Journal of Neurology. PMID 31359039 DOI: 10.1093/Brain/Awz226  0.627
2019 Specketer K, Zabetian CP, Edwards KL, Tian L, Quinn JF, Peterson-Hiller AL, Chung KA, Hu SC, Montine TJ, Cholerton BA. Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 31177941 DOI: 10.1080/13803395.2019.1623180  0.31
2019 Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, ... ... Montine TJ, et al. Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099) Brain. 142. PMID 31147685 DOI: 10.1093/Brain/Awz163  0.67
2019 Day TKM, Madhyastha TM, Lee A, Zabetian CP, Montine TJ, Grabowski T. Effect of dopaminergic medications on BOLD variability and functional connectivity in Parkinson's disease. Brain Connectivity. PMID 31131605 DOI: 10.1089/Brain.2019.0677  0.308
2019 Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, ... ... Montine TJ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain : a Journal of Neurology. PMID 31039256 DOI: 10.1093/Brain/Awz099  0.73
2019 Cholerton B, Weiner MW, Nosheny RL, Poston KL, Scott Mackin R, Tian L, Ashford JW, Montine TJ. Cognitive Performance in Parkinson's Disease in the Brain Health Registry. Journal of Alzheimer's Disease : Jad. PMID 30909225 DOI: 10.3233/Jad-181009  0.309
2019 Montine TJ, Cholerton BA, Corrada MM, Edland SD, Flanagan ME, Hemmy LS, Kawas CH, White LR. Concepts for brain aging: resistance, resilience, reserve, and compensation. Alzheimer's Research & Therapy. 11: 22. PMID 30857563 DOI: 10.1186/S13195-019-0479-Y  0.671
2019 Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, ... ... Montine TJ, et al. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 51: 414-430. PMID 30820047 DOI: 10.1038/s41588-019-0358-2  0.609
2019 Hendershott TR, Zhu D, Llanes S, Zabetian CP, Quinn J, Edwards KL, Leverenz JB, Montine T, Cholerton B, Poston KL. Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 285-291. PMID 30776152 DOI: 10.1002/Mds.27575  0.32
2019 Jagust W, Jack CR, Bennett DA, Blennow K, Haeberlein SB, Holtzman DM, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, et al. "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia". Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 15: 153-157. PMID 30642435 DOI: 10.1016/J.Jalz.2018.11.002  0.396
2019 Weiner MW, Nosheny RL, Mackin RS, Truran-Sacrey D, Flenniken D, Camacho MR, Kwang W, Howell T, Fockler J, Alosco ML, Stern RA, Montine TJ, Cholerton B, Ashford JW, Maruff P, et al. S4-01-01: IDENTIFYING ELDERS AT RISK FOR COGNITIVE DECLINE USING THE BRAIN HEALTH REGISTRY (BHR) Alzheimer's & Dementia. 15: P1215-P1215. DOI: 10.1016/J.Jalz.2019.06.4709  0.306
2019 Reiman EM, Arboleda-Velasquez JF, Quiroz YT, Huentelman MJ, Beach TG, Farrer LA, Mayeux R, Haines JL, Schellenberg GD, Beecham GW, Montine TJ, Jun GR. P4-259: Exceptionally Low Risk Of Alzheimer'S Dementia In Apoe2 Homozygotes Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3928  0.361
2018 Latimer CS, Shively CA, Keene CD, Jorgensen MJ, Andrews RN, Register TC, Montine TJ, Wilson AM, Neth BJ, Mintz A, Maldjian JA, Whitlow CT, Kaplan JR, Craft S. A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30467082 DOI: 10.1016/J.Jalz.2018.06.3057  0.42
2018 Flanagan ME, Cholerton B, Latimer CS, Hemmy LS, Edland SD, Montine KS, White LR, Montine TJ. TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study. Journal of Alzheimer's Disease : Jad. PMID 30452409 DOI: 10.3233/Jad-180162  0.703
2018 Besser LM, Kukull WA, Teylan MA, Bigio EH, Cairns NJ, Kofler JK, Montine TJ, Schneider JA, Nelson PT. The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses. Journal of Neuropathology and Experimental Neurology. PMID 29945202 DOI: 10.1093/Jnen/Nly049  0.414
2018 Knopman DS, Haeberlein SB, Carrillo MC, Hendrix JA, Kerchner G, Margolin R, Maruff P, Miller DS, Tong G, Tome MB, Murray ME, Nelson PT, Sano M, Mattsson N, Sultzer DL, ... Montine TJ, et al. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 563-575. PMID 29653607 DOI: 10.1016/J.Jalz.2018.03.002  0.358
2018 Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 14: 535-562. PMID 29653606 DOI: 10.1016/J.Jalz.2018.02.018  0.428
2018 Chung J, Zhang X, Allen M, Wang X, Ma Y, Beecham G, Montine TJ, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Lunetta KL, Mez J, et al. Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer's disease. Alzheimer's Research & Therapy. 10: 22. PMID 29458411 DOI: 10.1186/S13195-018-0349-Z  0.385
2018 Dumitrescu L, Deming Y, Lu Q, Beecham GW, Kunkle BW, Del-Aguila JL, Fernandez MV, Budde JP, Fagan AM, Jager PLD, Albert MS, Moghekar A, Riemenschneider M, Petersen RC, Barnes LL, ... ... Montine TJ, et al. P1-139: The Contribution Of Sex-Specific Associations In Genetic Studies Of Alzheimer'S Disease Pathology Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.142  0.383
2017 Flanagan ME, Larson EB, Walker RL, Keene CD, Postupna N, Cholerton B, Sonnen JA, Dublin S, Crane PK, Montine TJ. Associations between Use of Specific Analgesics and Concentrations of Amyloid-β 42 or Phospho-Tau in Regions of Human Cerebral Cortex. Journal of Alzheimer's Disease : Jad. PMID 29226863 DOI: 10.3233/Jad-170414  0.778
2017 Miller JA, Guillozet-Bongaarts A, Gibbons LE, Postupna N, Renz A, Beller AE, Sunkin SM, Ng L, Rose SE, Smith KA, Szafer A, Barber C, Bertagnolli D, Bickley K, Brouner K, ... ... Montine TJ, et al. Neuropathological and transcriptomic characteristics of the aged brain. Elife. 6. PMID 29120328 DOI: 10.7554/Elife.31126  0.424
2017 Crane PK, Foroud T, Montine TJ, Larson EB. Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29055816 DOI: 10.1016/J.Jalz.2017.09.010  0.307
2017 Latimer CS, Flanagan ME, Cimino PJ, Jayadev S, Davis M, Hoffer ZS, Montine TJ, Gonzalez-Cuyar LF, Bird TD, Keene CD. Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son. Journal of Huntington's Disease. PMID 29036832 DOI: 10.3233/Jhd-170261  0.771
2017 Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, Satpathy AT, Rubin AJ, Montine KS, Wu B, Kathiria A, Cho SW, Mumbach MR, Carter AC, Kasowski M, ... ... Montine TJ, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nature Methods. PMID 28846090 DOI: 10.1038/Nmeth.4396  0.375
2017 Bharadwaj R, Cimino PJ, Flanagan ME, Latimer CS, Gonzalez-Cuyar LF, Juric-Sekhar G, Montine TJ, Marshall DA, Keene CD. Application of the Condensed Protocol for the NIA-AA guidelines for the neuropathologic assessment of Alzheimer's disease in an academic clinical practice. Histopathology. PMID 28815699 DOI: 10.1111/His.13345  0.786
2017 Bettcher BM, Ard MC, Reed BR, Benitez A, Simmons A, Larson EB, Sonnen JA, Montine TJ, Li G, Keene CD, Crane PK, Mungas D. Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study. Journal of Alzheimer's Disease : Jad. PMID 28731431 DOI: 10.3233/Jad-161224  0.627
2017 Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, ... ... Montine TJ, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nature Genetics. PMID 28714976 DOI: 10.1038/Ng.3916  0.637
2017 Li G, Shofer JB, Petrie EC, Yu CE, Wilkinson CW, Figlewicz DP, Shutes-David A, Zhang J, Montine TJ, Raskind MA, Quinn JF, Galasko DR, Peskind ER. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimer's Research & Therapy. 9: 48. PMID 28673336 DOI: 10.1186/S13195-017-0271-9  0.459
2017 Baird G, Montine TJ, Chang JJ, Hu SC, Avellino AM. Cerebrospinal Fluid Total Tau is Increased in Normal Pressure Hydrocephalus Patients who Undergo Successful Lumbar Drain Trials. Cureus. 9: e1265. PMID 28652949 DOI: 10.7759/Cureus.1265  0.352
2017 McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, ... ... Montine TJ, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. PMID 28592453 DOI: 10.1212/Wnl.0000000000004058  0.345
2017 Latimer CS, Keene CD, Flanagan ME, Hemmy LS, Lim KO, White LR, Montine KS, Montine TJ. Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies. Journal of Neuropathology and Experimental Neurology. PMID 28499012 DOI: 10.1093/Jnen/Nlx030  0.703
2017 Dublin S, Walker RL, Gray SL, Hubbard RA, Anderson ML, Yu O, Montine TJ, Crane PK, Sonnen JA, Larson EB. Use of Analgesics (Opioids and Nonsteroidal Anti-Inflammatory Drugs) and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort. Journal of Alzheimer's Disease : Jad. PMID 28453469 DOI: 10.3233/Jad-160374  0.631
2017 Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, Dahl D, Caulder E, Neth B, Montine TJ, Jung Y, Maldjian J, Whitlow C, Friedman S. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial. Journal of Alzheimer's Disease : Jad. PMID 28372335 DOI: 10.3233/Jad-161256  0.358
2017 Chibnik LB, White CC, Mukherjee S, Raj T, Yu L, Larson EB, Montine TJ, Keene CD, Sonnen J, Schneider JA, Crane PK, Shulman JM, Bennett DA, De Jager PL. Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies. Molecular Psychiatry. PMID 28322283 DOI: 10.1038/Mp.2017.20  0.641
2017 Mukherjee S, Russell JC, Carr DT, Burgess JD, Younkin MA, Serie D, Boehme KL, Kauwe JS, Naj AC, Fardo DW, Dickson DW, Montine TJ, Ertekin-Taner N, Kaeberlein MR, Crane PK. Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28242297 DOI: 10.1016/J.Jalz.2017.01.016  0.371
2017 Flanagan ME, Marshall DA, Shofer JB, Montine KS, Nelson PT, Montine TJ, Keene CD. Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease. Journal of Neuropathology and Experimental Neurology. PMID 28062571 DOI: 10.1093/Jnen/Nlw104  0.719
2017 Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, Satpathy AT, Rubin AJ, Montine KS, Wu B, Kathiria A, Cho SW, Mumbach MR, Carter AC, Kasowski M, ... ... Montine TJ, et al. Omni-ATAC-seq: Improved ATAC-seq protocol Protocol Exchange. DOI: 10.1038/Protex.2017.096  0.394
2017 White LR, Liu C, Edland SD, Montine K, Launer LJ, Montine TJ. BRAINSTEM NEURONAL LOSS OCCURRING INDEPENDENTLY FROM NEOCORTICAL ALZHEIMER, LEWY BODY, OR FOCAL ISCHEMIC LESIONS IS COMMON AND SIGNIFICANTLY ASSOCIATED WITH BOTH MOTOR AND COGNITIVE IMPAIRMENT IN AUTOPSIED HONOLULU-ASIA AGING STUDY DECEDENTS Alzheimer's & Dementia. 13: P1470. DOI: 10.1016/J.Jalz.2017.07.544  0.329
2017 Khan RR, Napolioni V, Altmann A, Seeley WW, Montine TJ, Coppola G, Chen JA, Plowey ED, Channappa D, Gitler AD, Couthouis J, Flanagan ME, Greicius MD. IDENTIFICATION OF AN ITGA7 VARIANT ASSOCIATED WITH ALZHEIMER’S DISEASE AND MULTIPLE OTHER NEURODEGENERATIVE DISEASES Alzheimer's & Dementia. 13: P193-P194. DOI: 10.1016/J.Jalz.2017.07.050  0.694
2017 Siderowf AD, Dirk Keene C, Beach TG, Montine TJ, Arora A, Devous MD, Navitsky M, Kennedy I, Joshi AD, Pontecorvo MJ, Lu M, Serrano GE, Rose S, Wilson A, Hellstern L, et al. [P2-383]: COMPARISON OF REGIONAL FLORTAUCIPIR PET TO QUANTITATIVE TAU AND AMYLOID IMMUNOASSAY IN PATIENTS WITH ALZHEIMER's DISEASE PATHOLOGY: A PILOT CLINICO-PATHOLOGICAL STUDY Alzheimer's & Dementia. 13: P776-P776. DOI: 10.1016/J.Jalz.2017.06.1038  0.402
2016 Crane PK, Walker RL, Sonnen J, Gibbons LE, Melrose R, Hassenstab J, Keene CD, Postupna N, Montine TJ, Larson EB. Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes. Neurobiology of Aging. 48: 72-82. PMID 27644076 DOI: 10.1016/J.Neurobiolaging.2016.07.021  0.607
2016 Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, ... ... Montine TJ, et al. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. Jama Neurology. PMID 27571329 DOI: 10.1001/Jamaneurol.2016.2245  0.342
2016 Crane PK, Gibbons LE, Dams-O'Connor K, Trittschuh E, Leverenz JB, Keene CD, Sonnen J, Montine TJ, Bennett DA, Leurgans S, Schneider JA, Larson EB. Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. Jama Neurology. PMID 27400367 DOI: 10.1001/Jamaneurol.2016.1948  0.548
2016 Takeda S, Commins C, DeVos SL, Nobuhara CK, Wegmann S, Roe AD, Costantino I, Fan Z, Nicholls SB, Sherman AE, Trisini Lipsanopoulos AT, Scherzer CR, Carlson GA, Pitstick R, Peskind ER, ... ... Montine TJ, et al. Seed-competent HMW tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients. Annals of Neurology. PMID 27351289 DOI: 10.1002/Ana.24716  0.431
2016 Hoekstra JG, Hipp MJ, Montine TJ, Kennedy SR. Mitochondrial DNA Mutations Increase in Early Stage Alzheimer's Disease and are Inconsistent with Oxidative Damage. Annals of Neurology. PMID 27315116 DOI: 10.1002/Ana.24709  0.755
2016 Henderson BW, Gentry EG, Rush T, Troncoso JC, Thambisetty M, Montine TJ, Herskowitz JH. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain. Journal of Neurochemistry. PMID 27246255 DOI: 10.1111/Jnc.13688  0.406
2016 Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, ... ... Montine TJ, et al. CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27234211 DOI: 10.1016/J.Jalz.2016.04.003  0.703
2016 McNeal DW, Brandner DD, Gong X, Postupna NO, Montine TJ, Dirk Keene C, Back SA. Unbiased Stereological Analysis of Reactive Astrogliosis to Estimate Age-Associated Cerebral White Matter Injury. Journal of Neuropathology and Experimental Neurology. PMID 27142644 DOI: 10.1093/Jnen/Nlw032  0.32
2016 Serrano-Pozo A, Qian J, Muzikansky A, Monsell SE, Montine TJ, Frosch MP, Betensky RA, Hyman BT. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum. Journal of Neuropathology and Experimental Neurology. PMID 27105663 DOI: 10.1093/Jnen/Nlw026  0.377
2016 Davis MY, Trinh K, Thomas RE, Yu S, Germanos AA, Whitley BN, Sardi SP, Montine TJ, Pallanck LJ. Glucocerebrosidase Deficiency in Drosophila Results in α-Synuclein-Independent Protein Aggregation and Neurodegeneration. Plos Genetics. 12: e1005944. PMID 27019408 DOI: 10.1371/Journal.Pgen.1005944  0.302
2016 Melief EJ, Gibbs JT, Li X, Morgan RG, Keene CD, Montine TJ, Palmiter RD, Darvas M. Characterization of cognitive impairments and neurotransmitter changes in a novel transgenic mouse lacking Slc10a4. Neuroscience. PMID 27001174 DOI: 10.1016/J.Neuroscience.2016.03.037  0.305
2016 White LR, Edland SD, Hemmy LS, Montine KS, Zarow C, Sonnen JA, Uyehara-Lock JH, Gelber RP, Ross GW, Petrovitch H, Masaki KH, Lim KO, Launer LJ, Montine TJ. Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies. Neurology. PMID 26888993 DOI: 10.1212/Wnl.0000000000002480  0.616
2016 White LR, Willis EA, Hemmy LS, Montine K, Launer LJ, Edland SD, Montine TJ. P2-118: Puzzle: Why is the Exponential Increase in Age-Specific Prevalence of Alzheimer’s Disease (AD) not Paralleled by the Prevalence Curve for AD Brain Lesions at Autopsy? Observations from the Nun Study (NS) and Honolulu-Asia Aging Study (HAAS) Alzheimer's & Dementia. 12: P657-P657. DOI: 10.1016/J.Jalz.2016.06.1488  0.387
2015 Cholerton B, Larson EB, Quinn JF, Zabetian CP, Mata IF, Keene CD, Flanagan M, Crane PK, Grabowski TJ, Montine KS, Montine TJ. Precision Medicine: Clarity for the Complexity of Dementia. The American Journal of Pathology. PMID 26724389 DOI: 10.1016/J.Ajpath.2015.12.001  0.714
2015 Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, ... ... Montine TJ, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/S00401-015-1509-X  0.354
2015 Crane PK, Gibbons LE, McCurry SM, McCormick W, Bowen JD, Sonnen J, Keene CD, Grabowski T, Montine TJ, Larson EB. Importance of home study visit capacity in dementia studies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26602628 DOI: 10.1016/J.Jalz.2015.10.007  0.667
2015 Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau. Journal of Alzheimer's Disease : Jad. 47: 883-7. PMID 26401768 DOI: 10.3233/Jad-150420  0.452
2015 Shang J, Zrazhevskiy P, Postupna N, Keene CD, Montine TJ, Gao X. Multiplexed In-cell Immunoassay for Same-sample Protein Expression Profiling. Scientific Reports. 5: 13651. PMID 26328896 DOI: 10.1038/Srep13651  0.317
2015 Montine TJ, Monsell SE, Beach TG, Bigio EH, Bu Y, Cairns NJ, Frosch M, Henriksen J, Kofler J, Kukull WA, Lee EB, Nelson PT, Schantz AM, Schneider JA, Sonnen JA, et al. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26327235 DOI: 10.1016/J.Jalz.2015.07.492  0.66
2015 Flanagan M, Larson EB, Latimer CS, Cholerton B, Crane PK, Montine KS, White LR, Dirk Keene C, Montine TJ. Clinical-pathologic correlations in vascular cognitive impairment and dementia. Biochimica Et Biophysica Acta. PMID 26319420 DOI: 10.1016/J.Bbadis.2015.08.019  0.721
2015 Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. Jama Neurology. PMID 26302353 DOI: 10.1001/Jamaneurol.2015.1721  0.385
2015 Madhyastha TM, Askren MK, Zhang J, Leverenz JB, Montine TJ, Grabowski TJ. Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson's disease. Brain : a Journal of Neurology. 138: 2672-86. PMID 26173859 DOI: 10.1093/Brain/Awv189  0.361
2015 Yang Y, Keene CD, Peskind ER, Galasko DR, Hu SC, Cudaback E, Wilson AM, Li G, Yu CE, Montine KS, Zhang J, Baird GS, Hyman BT, Montine TJ. Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. Journal of Neuropathology and Experimental Neurology. 74: 672-87. PMID 26083568 DOI: 10.1097/Nen.0000000000000207  0.436
2015 Montine TJ, Montine KS. Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases. The Journal of Experimental Medicine. 212: 601-5. PMID 25941321 DOI: 10.1084/Jem.20150656  0.362
2015 Melief EJ, Cudaback E, Jorstad NL, Sherfield E, Postupna N, Wilson A, Darvas M, Montine KS, Keene CD, Montine TJ. Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease. Journal of Neuroscience Research. 93: 1413-22. PMID 25824456 DOI: 10.1002/Jnr.23592  0.417
2015 Bekris LM, Tsuang DW, Peskind ER, Yu CE, Montine TJ, Zhang J, Zabetian CP, Leverenz JB. Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 936-44. PMID 25808939 DOI: 10.1002/Mds.26172  0.451
2015 Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, Dickson DW, Hof PR, Hyman BT, Jack CR, Jicha GA, Knopman DS, Kovacs GG, Mackenzie IR, Masliah E, ... Montine TJ, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathologica. 129: 757-62. PMID 25778618 DOI: 10.1007/S00401-015-1407-2  0.427
2015 Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellenguez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, ... ... Montine TJ, et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Molecular Psychiatry. PMID 25778476 DOI: 10.1038/Mp.2015.23  0.342
2015 Beecham GW, Dickson DW, Scott WK, Martin ER, Schellenberg G, Nuytemans K, Larson EB, Buxbaum JD, Trojanowski JQ, Van Deerlin VM, Hurtig HI, Mash DC, Beach TG, Troncoso JC, Pletnikova O, ... ... Montine TJ, et al. PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease. Neurology. 84: 972-80. PMID 25663231 DOI: 10.1212/Wnl.0000000000001332  0.323
2015 Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, ... ... Montine TJ, et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 728-33. PMID 25650144 DOI: 10.1002/Mds.26161  0.37
2015 Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 709-19. PMID 25613100 DOI: 10.3233/Jad-143099  0.436
2015 Li X, Montine KS, Keene CD, Montine TJ. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1754-62. PMID 25593125 DOI: 10.1096/Fj.14-262683  0.347
2015 Postupna N, Keene CD, Crane PK, Gonzalez-Cuyar LF, Sonnen JA, Hewitt J, Rice S, Howard K, Montine KS, Larson EB, Montine TJ. Cerebral cortical Aβ42 and PHF-Ï„ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE. Journal of Neuropathology and Experimental Neurology. 74: 100-9. PMID 25575135 DOI: 10.1097/Nen.0000000000000153  0.688
2015 Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, ... ... Montine TJ, et al. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. Jama Neurology. 72: 209-16. PMID 25531812 DOI: 10.1001/Jamaneurol.2014.2157  0.663
2015 Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 710-717. PMID 25510382 DOI: 10.1016/J.Jalz.2014.10.008  0.391
2015 Cudaback E, Yang Y, Montine TJ, Keene CD. APOE genotype-dependent modulation of astrocyte chemokine CCL3 production. Glia. 63: 51-65. PMID 25092803 DOI: 10.1002/Glia.22732  0.396
2015 White LR, Zarow C, Gelber R, Sonnen J, Uyehara-Lock J, Montine T, Launer LJ, Edland S. P3-024: Cognitive resilience and vulnerability to Alzheimer brain lesions in the honolulu-asia aging study (HAAS) Alzheimer's & Dementia. 11: P628-P629. DOI: 10.1016/J.Jalz.2015.06.890  0.633
2015 White LR, Gelber R, Zarow C, Sonnen J, Uyehara-Lock J, Launer LJ, Montine T, Edland S. P2-029: Dementia and motor impairments: Independent development and neuropathologic substrates in the honolulu-asia aging study (HAAS) Alzheimer's & Dementia. 11: P492-P492. DOI: 10.1016/J.Jalz.2015.06.565  0.603
2015 Bettcher BM, Ard MC, Reed B, Benitez A, Simmons A, Larson EB, Sonnen J, Montine TJ, Li G, Keene CD, Crane PK, Mungas D. P1-246: Association between cholesterol exposure and neuropathological findings: The adult changes in thought study Alzheimer's & Dementia. 11: P447-P448. DOI: 10.1016/J.Jalz.2015.06.446  0.579
2015 Edland SD, Gelber R, Zarow C, Uyehara-Lock J, Sonnen J, Montine T, Launer LJ, White LR. P1-209: Cerebral amyloid angiopathy is not associated with late-life cognitive performance in the honolulu asia aging study Alzheimer's & Dementia. 11: P430-P431. DOI: 10.1016/J.Jalz.2015.06.409  0.619
2014 Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, Arnold SE, Attems J, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Gearing M, Grinberg LT, Hof PR, ... ... Montine TJ, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathologica. 128: 755-66. PMID 25348064 DOI: 10.1007/S00401-014-1349-0  0.448
2014 Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, ... ... Montine TJ, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. Jama Neurology. 71: 1394-404. PMID 25199842 DOI: 10.1001/Jamaneurol.2014.1491  0.635
2014 Yang Y, Aloi MS, Cudaback E, Josephsen SR, Rice SJ, Jorstad NL, Keene CD, Montine TJ. Wild-type bone marrow transplant partially reverses neuroinflammation in progranulin-deficient mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 1224-36. PMID 25199051 DOI: 10.1038/Labinvest.2014.113  0.307
2014 Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG, Bennett DA, De Jager PL, Larson EB, Crane PK, Kamboh MI, ... ... Montine TJ, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. Plos Genetics. 10: e1004606. PMID 25188341 DOI: 10.1371/Journal.Pgen.1004606  0.432
2014 Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Hurtig HI, Van Deerlin VM, Ritz B, Rausch R, Rhodes SL, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson AL, Espay AJ, ... ... Montine TJ, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. Jama Neurology. 71: 1405-12. PMID 25178429 DOI: 10.1001/Jamaneurol.2014.1455  0.322
2014 Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML, Knopman DS, Kuzmichev AN, Manly JJ, Marder KS, Miller BL, Phelps CH, Seeley WW, et al. Recommendations of the Alzheimer's disease-related dementias conference. Neurology. 83: 851-60. PMID 25080517 DOI: 10.1212/Wnl.0000000000000733  0.392
2014 Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, ... Montine TJ, et al. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1258-64. PMID 25073717 DOI: 10.1002/Mds.25924  0.341
2014 Postupna NO, Keene CD, Latimer C, Sherfield EE, Van Gelder RD, Ojemann JG, Montine TJ, Darvas M. Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. Laboratory Investigation; a Journal of Technical Methods and Pathology. 94: 1161-72. PMID 25068655 DOI: 10.1038/Labinvest.2014.103  0.418
2014 Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, ... ... Montine TJ, et al. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. Plos One. 9: e94661. PMID 24922517 DOI: 10.1371/Journal.Pone.0094661  0.367
2014 Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, ... ... Montine TJ, et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathologica. 127: 825-43. PMID 24770881 DOI: 10.1007/S00401-014-1282-2  0.628
2014 Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, Galasko DR, Montine TJ. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. Jama Neurology. 71: 742-51. PMID 24756381 DOI: 10.1001/Jamaneurol.2014.445  0.419
2014 Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL. Evaluation of mild cognitive impairment subtypes in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 756-64. PMID 24710804 DOI: 10.1002/Mds.25875  0.318
2014 Nuytemans K, Inchausti V, Beecham GW, Wang L, Dickson DW, Trojanowski JQ, Lee VM, Mash DC, Frosch MP, Foroud TM, Honig LS, Montine TJ, Dawson TM, Martin ER, Scott WK, et al. Absence of C9ORF72 expanded or intermediate repeats in autopsy-confirmed Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 827-30. PMID 24573903 DOI: 10.1002/Mds.25838  0.326
2014 Cudaback E, Jorstad NL, Yang Y, Montine TJ, Keene CD. Therapeutic implications of the prostaglandin pathway in Alzheimer's disease. Biochemical Pharmacology. 88: 565-72. PMID 24434190 DOI: 10.1016/J.Bcp.2013.12.014  0.405
2014 Dublin S, Anderson ML, Heckbert SR, Hubbard RA, Sonnen JA, Crane PK, Montine TJ, Larson EB. Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 69: 609-15. PMID 24077599 DOI: 10.1093/Gerona/Glt141  0.615
2014 Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 38: 111-20. PMID 24077434 DOI: 10.3233/Jad-130722  0.374
2014 Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, et al. The future of blood-based biomarkers for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 115-31. PMID 23850333 DOI: 10.1016/J.Jalz.2013.01.013  0.401
2014 LaCroix A, Hubbard RA, Gray S, Crane PK, Anderson M, Keene CD, Sonnen J, Montine TJ, Larson EB. P2-292: TRAJECTORIES OF PHYSICAL FUNCTION PRIOR TO DEATH AND BRAIN NEUROPATHOLOGY IN THE ADULT CHANGES IN THOUGHT (ACT) AUTOPSY COHORT Alzheimer's & Dementia. 10: P584-P585. DOI: 10.1016/J.Jalz.2014.05.970  0.597
2014 Sonnen J, Walker R, Gray S, Crane P, Montine T, Larson EB. P1-314: ASSOCIATIONS BETWEEN CARDIOPROTECTIVE DOSES OF ASPIRIN AND AGE-RELATED NEUROPATHOLOGY Alzheimer's & Dementia. 10: P426-P427. DOI: 10.1016/J.Jalz.2014.05.555  0.575
2014 Monsell SE, Caselli RJ, Kukull WA, Beach TG, Montine TJ, Reiman EM. Apoe4 Non-Carriers With The Clinical Diagnosis Of Alzheimer'S Dementia And Minimal Amyloid Histopathology Alzheimers & Dementia. 10: 423. DOI: 10.1016/J.Jalz.2014.05.547  0.379
2014 Postupna NO, Hewitt JL, Sonnen JA, Larson EB, Crane PK, Keene CD, Montine TJ. P1-305: CORTICAL BURDEN OF AMYLOID BETA AND PHF TAU IN DEMENTED AND NON-DEMENTED INDIVIDUALS Alzheimer's & Dementia. 10: P423-P423. DOI: 10.1016/J.Jalz.2014.05.546  0.603
2014 Peskind ER, Petrie EC, Pagulayan KF, Yarnykh V, Cross DJ, Richards T, Raskind MA, Zhang J, Montine T, Minoshima S. Persistent Brain Neuroimaging And Neurocognitive Abnormalities In Military Veterans Who Experienced Blast Mild Traumatic Brain Injury In Iraq And Afghanistan Alzheimers & Dementia. 10: 294. DOI: 10.1016/J.Jalz.2014.04.487  0.329
2014 Chibnik LB, White CC, Raj T, Mukherjee S, Shulman JM, Crane P, Montine T, Bennett D, Jager PD. A Novel Susceptibility Locus For Neurofibrillary Tangles At Ptprd: Evidence Of Pleiotropic Effects On Other Brain Pathologies Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.403  0.339
2014 Keene CD, Gibbons LE, Sonnen J, Dams-O'Connor K, Walker R, Montine T, Larson EB, Crane P. O3-11-04: ASSOCIATIONS BETWEEN LIFETIME HISTORY OF TRAUMATIC BRAIN INJURY AND DEMENTIA-RELATED NEUROPATHOLOGICAL FINDINGS AT AUTOPSY: THE ADULT CHANGES IN THOUGHT STUDY Alzheimer's & Dementia. 10: P231-P232. DOI: 10.1016/J.Jalz.2014.04.332  0.614
2014 Crane PK, Walker R, Gibbons LE, Melrose RJ, Hassenstab J, Hubbard RA, Sonnen J, Keene CD, Postupna N, Montine TJ, Larson EB. O2-09-03: ASSOCIATIONS BETWEEN GLUCOSE LEVELS AND NEUROPATHOLOGICAL ENDPOINTS AMONG PEOPLE NEVER TREATED FOR DIABETES: THE ADULT CHANGES IN THOUGHT STUDY Alzheimer's & Dementia. 10: P182-P184. DOI: 10.1016/J.Jalz.2014.04.206  0.561
2013 Herskowitz JH, Feng Y, Mattheyses AL, Hales CM, Higginbotham LA, Duong DM, Montine TJ, Troncoso JC, Thambisetty M, Seyfried NT, Levey AI, Lah JJ. Pharmacologic inhibition of ROCK2 suppresses amyloid-β production in an Alzheimer's disease mouse model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19086-98. PMID 24305806 DOI: 10.1523/Jneurosci.2508-13.2013  0.312
2013 Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, Smith AV, Chouraki V, ... ... Montine TJ, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics. 45: 1452-8. PMID 24162737 DOI: 10.1038/Ng.2802  0.368
2013 Hales CM, Rees H, Seyfried NT, Dammer EB, Duong DM, Gearing M, Montine TJ, Troncoso JC, Thambisetty M, Levey AI, Lah JJ, Wingo TS. Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes. Journal of Neuropathology and Experimental Neurology. 72: 1009-15. PMID 24128675 DOI: 10.1097/01.Jnen.0000435847.59828.Db  0.317
2013 Bai B, Hales CM, Chen PC, Gozal Y, Dammer EB, Fritz JJ, Wang X, Xia Q, Duong DM, Street C, Cantero G, Cheng D, Jones DR, Wu Z, Li Y, ... ... Montine TJ, et al. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 16562-7. PMID 24023061 DOI: 10.1073/Pnas.1310249110  0.301
2013 Cholerton BA, Zabetian CP, Quinn JF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Edwards KL, Montine TJ, Leverenz JB. Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics. Journal of Parkinson's Disease. 3: 205-14. PMID 23938350 DOI: 10.3233/Jpd-130189  0.315
2013 Yu CE, Cudaback E, Foraker J, Thomson Z, Leong L, Lutz F, Gill JA, Saxton A, Kraemer B, Navas P, Keene CD, Montine T, Bekris LM. Epigenetic signature and enhancer activity of the human APOE gene. Human Molecular Genetics. 22: 5036-47. PMID 23892237 DOI: 10.1093/Hmg/Ddt354  0.387
2013 Yang Y, Cudaback E, Jorstad NL, Hemingway JF, Hagan CE, Melief EJ, Li X, Yoo T, Khademi SB, Montine KS, Montine TJ, Keene CD. APOE3, but not APOE4, bone marrow transplantation mitigates behavioral and pathological changes in a mouse model of Alzheimer disease. The American Journal of Pathology. 183: 905-17. PMID 23831297 DOI: 10.1016/J.Ajpath.2013.05.009  0.748
2013 Bekris LM, Lutz F, Montine TJ, Yu CE, Tsuang D, Peskind ER, Leverenz JB. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 18: 455-66. PMID 23822153 DOI: 10.3109/1354750X.2013.814073  0.314
2013 Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. Jama Neurology. 70: 972-80. PMID 23779114 DOI: 10.1001/Jamaneurol.2013.396  0.384
2013 Cholerton B, Larson EB, Baker LD, Craft S, Crane PK, Millard SP, Sonnen JA, Montine TJ. Neuropathologic correlates of cognition in a population-based sample. Journal of Alzheimer's Disease : Jad. 36: 699-709. PMID 23666176 DOI: 10.3233/Jad-130281  0.658
2013 Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, ... ... Montine TJ, et al. APOE ε4 increases risk for dementia in pure synucleinopathies. Jama Neurology. 70: 223-8. PMID 23407718 DOI: 10.1001/Jamaneurol.2013.600  0.396
2013 Cimino PJ, Yang Y, Li X, Hemingway JF, Cherne MK, Khademi SB, Fukui Y, Montine KS, Montine TJ, Keene CD. Ablation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease. Experimental and Molecular Pathology. 94: 366-71. PMID 23318649 DOI: 10.1016/J.Yexmp.2013.01.002  0.682
2013 Watson GS, Cholerton BA, Gross RG, Weintraub D, Zabetian CP, Trojanowski JQ, Montine TJ, Siderowf A, Leverenz JB. Neuropsychologic assessment in collaborative Parkinson's disease research: a proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson's Disease Research at the University of Pennsylvania and the University of Washington. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 609-14. PMID 23164549 DOI: 10.1016/J.Jalz.2012.07.006  0.323
2013 Montine KS, Montine TJ. Anatomic and clinical pathology of cognitive impairment and dementia. Journal of Alzheimer's Disease : Jad. 33: S181-4. PMID 22699849 DOI: 10.3233/Jad-2012-129032  0.4
2013 Peskind E, Petrie E, Cross D, Li G, Mayer C, Minoshima S, Zhang J, Montine T, Raskind M. Cerebrospinal fluid biomarkers and PET imaging of cerebral glucose metabolism in Iraq and Afghanistan veterans: Converging evidence of brain dysfunction and neurodegeneration Alzheimers & Dementia. 9: 229. DOI: 10.1016/J.Jalz.2013.05.434  0.328
2013 Melief E, Sherfield E, Keene DC, Montine T. P1-101: Ablation of striatal dopamine exacerbates cognitive impairment in a mouse model of Alzheimer's disease Alzheimer's & Dementia. 9: P188-P188. DOI: 10.1016/J.Jalz.2013.05.323  0.363
2013 Beecham G, Hamilton-Nelson K, Naj A, Wang L, Martin E, Mayeux R, Haines J, Farrer L, Schellenberg G, Pericak-Vance M, Montine T. O4-06-04: Late-onset Alzheimer's disease neuropathology genomic screen identifies novel loci for neuritic plaque and other Alzheimer's neuropathology features Alzheimer's & Dementia. 9: P693-P693. DOI: 10.1016/J.Jalz.2013.04.368  0.375
2013 Higginbotham L, Donovan L, Duong D, Dammer E, Schantz A, Montine T, Lah J, Levey A, Seyfried N. O2-08-06: Analysis of the synapse-rich brain proteome reveals potential markers of asymptomatic Alzheimer's disease Alzheimer's & Dementia. 9: P331-P331. DOI: 10.1016/J.Jalz.2013.04.182  0.365
2012 Lin X, Cook TJ, Zabetian CP, Leverenz JB, Peskind ER, Hu SC, Cain KC, Pan C, Edgar JS, Goodlett DR, Racette BA, Checkoway H, Montine TJ, Shi M, Zhang J. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports. 2: 954. PMID 23233873 DOI: 10.1038/Srep00954  0.67
2012 Chan WF, Gurnot C, Montine TJ, Sonnen JA, Guthrie KA, Nelson JL. Male microchimerism in the human female brain. Plos One. 7: e45592. PMID 23049819 DOI: 10.1371/Journal.Pone.0045592  0.612
2012 Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ. Neuropathologic substrates of Parkinson disease dementia. Annals of Neurology. 72: 587-98. PMID 23037886 DOI: 10.1002/Ana.23659  0.401
2012 Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, ... ... Montine TJ, et al. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 79: 1944-50. PMID 23035075 DOI: 10.1212/Wnl.0B013E3182735E9A  0.403
2012 Mielke MM, Montine T, Khachaturian AS. Vascular diseases: one pathway toward new conceptual models of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: S69-70. PMID 23021623 DOI: 10.1016/J.Jalz.2012.09.001  0.324
2012 Cudaback E, Li X, Yang Y, Yoo T, Montine KS, Craft S, Montine TJ, Keene CD. Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation. Journal of Neuroinflammation. 9: 192. PMID 22883744 DOI: 10.1186/1742-2094-9-192  0.385
2012 Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, ... ... Montine TJ, et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 79: 221-8. PMID 22722634 DOI: 10.1212/Wnl.0B013E3182605801  0.582
2012 Mukherjee S, Kim S, Gibbons LE, Nho K, Risacher SL, Glymour MM, Habeck C, Lee GJ, Mormino E, Ertekin-Taner N, Montine TJ, Decarli C, Saykin AJ, Crane PK. Genetic architecture of resilience of executive functioning. Brain Imaging and Behavior. 6: 621-33. PMID 22711244 DOI: 10.1007/S11682-012-9184-1  0.364
2012 Schellenberg GD, Montine TJ. The genetics and neuropathology of Alzheimer's disease. Acta Neuropathologica. 124: 305-23. PMID 22618995 DOI: 10.1007/S00401-012-0996-2  0.39
2012 Bekris LM, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Montine TJ, Peskind ER, Yu CE. ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiology of Aging. 33: 2229.e1-2229.e9. PMID 22572541 DOI: 10.1016/J.Neurobiolaging.2012.03.013  0.422
2012 Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, ... ... Montine TJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/Nen.0B013E31825018F7  0.751
2012 Montine TJ, Sonnen JA, Montine KS, Crane PK, Larson EB. Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics. Current Alzheimer Research. 9: 718-23. PMID 22471861 DOI: 10.2174/156720512801322555  0.678
2012 Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Archives of Neurology. 69: 836-41. PMID 22431837 DOI: 10.1001/Archneurol.2012.85  0.375
2012 Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, ... ... Montine TJ, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 1-13. PMID 22265587 DOI: 10.1016/J.Jalz.2011.10.007  0.453
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/S00259-011-2045-0  0.338
2012 Baird GS, Nelson SK, Keeney TR, Stewart A, Williams S, Kraemer S, Peskind ER, Montine TJ. Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array. The American Journal of Pathology. 180: 446-56. PMID 22122984 DOI: 10.1016/J.Ajpath.2011.10.024  0.324
2012 Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathologica. 123: 1-11. PMID 22101365 DOI: 10.1007/S00401-011-0910-3  0.448
2012 Postupna N, Rose SE, Bird TD, Gonzalez-Cuyar LF, Sonnen JA, Larson EB, Keene CD, Montine TJ. Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults. Brain Pathology (Zurich, Switzerland). 22: 472-84. PMID 21999410 DOI: 10.1111/J.1750-3639.2011.00542.X  0.67
2012 Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S. High-intensity physical activity modulates diet effects on cerebrospinal amyloid-β levels in normal aging and mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 28: 137-46. PMID 21971406 DOI: 10.3233/Jad-2011-111076  0.317
2012 Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of Neurology. 69: 29-38. PMID 21911655 DOI: 10.1001/Archneurol.2011.233  0.346
2012 Irwin D, White M, Toledo J, Xie S, Robinson J, Van Deerlin V, Leverenz J, Montine T, Lee V, Duda J, Hurtig H, Trojanowski J. Neuropathologic substrates of Parkinson's disease dementia (S52.002) Neurology. 78: S52.002-S52.002. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S52.002  0.362
2012 Peterson A, Breitner J, Kaye J, Bowman G, Baker L, Clemons A, Montine T, Quinn J. Plasma Vitamin D, Cognitive Function, and Cerebrospinal Fluid Biomarkers in Subjects at Risk of Alzheimer's Disease (P02.064) Neurology. 78: P02.064-P02.064. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P02.064  0.342
2012 Beecham G, Montine T, Rajbhandary R, Hamilton-Nelson K, Naj A, Martin E, Mayeux R, Haines J, Farrer L, Schellenberg G, Pericak-Vance M. P4-102: APP associated with late-onset Alzheimer's disease in an autopsy-confirmed dataset Alzheimer's & Dementia. 8: P668-P668. DOI: 10.1016/J.Jalz.2012.05.1805  0.404
2012 Quinn J, Shinto L, Yurko-Mauro K, Galasko D, Aisen P, Montine T. P3-368: Biomarkers of fatty acid oxidation in a clinical trial of DHA for Alzheimer's disease Alzheimer's & Dementia. 8: P585-P585. DOI: 10.1016/J.Jalz.2012.05.1593  0.35
2011 Keene CD, Cudaback E, Li X, Montine KS, Montine TJ. Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease. Current Opinion in Neurobiology. 21: 920-8. PMID 21907569 DOI: 10.1016/J.Conb.2011.08.002  0.424
2011 Back SA, Kroenke CD, Sherman LS, Lawrence G, Gong X, Taber EN, Sonnen JA, Larson EB, Montine TJ. White matter lesions defined by diffusion tensor imaging in older adults. Annals of Neurology. 70: 465-76. PMID 21905080 DOI: 10.1002/Ana.22484  0.62
2011 Sonnen JA, Santa Cruz K, Hemmy LS, Woltjer R, Leverenz JB, Montine KS, Jack CR, Kaye J, Lim K, Larson EB, White L, Montine TJ. Ecology of the aging human brain. Archives of Neurology. 68: 1049-56. PMID 21825242 DOI: 10.1001/Archneurol.2011.157  0.656
2011 Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, ... ... Montine TJ, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 386-395.e6. PMID 21784349 DOI: 10.1016/J.Jalz.2011.05.2243  0.408
2011 Gonzalez-Cuyar LF, Sonnen JA, Montine KS, Keene CD, Montine TJ. Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment. Current Neurology and Neuroscience Reports. 11: 455-63. PMID 21725901 DOI: 10.1007/S11910-011-0212-0  0.642
2011 Hoekstra JG, Montine KS, Zhang J, Montine TJ. Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease. Alzheimer's Research & Therapy. 3: 21. PMID 21722346 DOI: 10.1186/Alzrt83  0.782
2011 Davies SS, Bodine C, Matafonova E, Pantazides BG, Bernoud-Hubac N, Harrison FE, Olson SJ, Montine TJ, Amarnath V, Roberts LJ. Treatment with a γ-ketoaldehyde scavenger prevents working memory deficits in hApoE4 mice. Journal of Alzheimer's Disease : Jad. 27: 49-59. PMID 21709376 DOI: 10.3233/Jad-2011-102118  0.37
2011 Hata S, Fujishige S, Araki Y, Taniguchi M, Urakami K, Peskind E, Akatsu H, Araseki M, Yamamoto K, Martins RN, Maeda M, Nishimura M, Levey A, Chung KA, Montine T, et al. Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and Alzheimer's disease: evidence for γ-secretase dysfunction. Annals of Neurology. 69: 1026-31. PMID 21681798 DOI: 10.1002/Ana.22343  0.382
2011 Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Walter BK, Tsai E, Plymate SR, Postupna N, Wilkinson CW, Zhang J, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Archives of Neurology. 68: 743-52. PMID 21670398 DOI: 10.1001/Archneurol.2011.125  0.348
2011 Montine TJ. Parkinson disease: PD biomarkers-use of α-synuclein reaches new levels. Nature Reviews. Neurology. 7: 308-9. PMID 21556033 DOI: 10.1038/Nrneurol.2011.66  0.357
2011 Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 280-92. PMID 21514248 DOI: 10.1016/J.Jalz.2011.03.003  0.44
2011 Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, ... ... Montine TJ, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics. 43: 436-41. PMID 21460841 DOI: 10.1038/Ng.801  0.584
2011 Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, et al. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. The American Journal of Pathology. 178: 1509-16. PMID 21435440 DOI: 10.1016/J.Ajpath.2011.01.006  0.445
2011 Jayadev S, Nochlin D, Poorkaj P, Steinbart EJ, Mastrianni JA, Montine TJ, Ghetti B, Schellenberg GD, Bird TD, Leverenz JB. Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Annals of Neurology. 69: 712-20. PMID 21416485 DOI: 10.1002/Ana.22264  0.392
2011 Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Annals of Neurology. 69: 570-80. PMID 21400565 DOI: 10.1002/Ana.22311  0.395
2011 Cudaback E, Li X, Montine KS, Montine TJ, Keene CD. Apolipoprotein E isoform-dependent microglia migration. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 2082-91. PMID 21385991 DOI: 10.1096/Fj.10-176891  0.351
2011 Montine TJ. Prevalence estimates for latent neurodegenerative disease. Toxicologic Pathology. 39: 99-102. PMID 21177526 DOI: 10.1177/0192623310391481  0.377
2011 Leverenz JB, Watson GS, Shofer J, Zabetian CP, Zhang J, Montine TJ. Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease. Parkinsonism & Related Disorders. 17: 61-4. PMID 21044858 DOI: 10.1016/J.Parkreldis.2010.10.003  0.427
2011 Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers. Neuromolecular Medicine. 13: 37-43. PMID 20632131 DOI: 10.1007/S12017-010-8126-6  0.414
2011 Hsu PC, Tsay HJ, Montine TJ, Shie FS. The effects of co-treatment of 9-cis-retinoic acid and 15-deoxy-δ (12,14)-prostaglandin J2 on microglial activation Molecules. 16: 4045-4058. DOI: 10.3390/Molecules16054045  0.318
2011 Sonnen J, Larson E, Lopez A, Walker R, Montine T. O2-07-06: Alteration in structural proteins in white matter injury is associated with vascular brain injury Alzheimer's & Dementia. 7: S305-S305. DOI: 10.1016/J.Jalz.2011.05.886  0.577
2010 Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2682-5. PMID 20818673 DOI: 10.1002/Mds.23287  0.401
2010 Sonnen JA, Larson EB, Walker RL, Haneuse S, Crane PK, Gray SL, Breitner JC, Montine TJ. Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology. 75: 1203-10. PMID 20811000 DOI: 10.1212/Wnl.0B013E3181F52Db1  0.657
2010 Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, ... ... Montine TJ, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology. 67: 1473-84. PMID 20697030 DOI: 10.1001/Archneurol.2010.201  0.354
2010 Woltjer RL, Duerson K, Fullmer JM, Mookherjee P, Ryan AM, Montine TJ, Kaye JA, Quinn JF, Silbert L, Erten-Lyons D, Leverenz JB, Bird TD, Pow DV, Tanaka K, Watson GS, et al. Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 69: 667-76. PMID 20535038 DOI: 10.1097/Nen.0B013E3181E24Adb  0.439
2010 Keene CD, Chang RC, Lopez-Yglesias AH, Shalloway BR, Sokal I, Li X, Reed PJ, Keene LM, Montine KS, Breyer RM, Rockhill JK, Montine TJ. Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow. The American Journal of Pathology. 177: 346-54. PMID 20522650 DOI: 10.2353/Ajpath.2010.090840  0.322
2010 Sonnen JA, Postupna N, Larson EB, Crane PK, Rose SE, Montine KS, Leverenz JB, Montine TJ. Pathologic correlates of dementia in individuals with Lewy body disease. Brain Pathology (Zurich, Switzerland). 20: 654-9. PMID 20522091 DOI: 10.1111/J.1750-3639.2009.00371.X  0.673
2010 Shi J, Johansson J, Woodling NS, Wang Q, Montine TJ, Andreasson K. The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. Journal of Immunology (Baltimore, Md. : 1950). 184: 7207-18. PMID 20483760 DOI: 10.4049/Jimmunol.0903487  0.332
2010 Snyder LR, Hoggard JC, Montine TJ, Synovec RE. Development and application of a comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method for the analysis of L-beta-methylamino-alanine in human tissue. Journal of Chromatography. A. 1217: 4639-47. PMID 20483417 DOI: 10.1016/J.Chroma.2010.04.065  0.611
2010 Galasko D, Montine TJ. Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomarkers in Medicine. 4: 27-36. PMID 20383271 DOI: 10.2217/Bmm.09.89  0.411
2010 Rostomily RC, Born DE, Beyer RP, Jin J, Alvord EC, Mikheev AM, Matthews RT, Pan C, Khorasani L, Sonnen JA, Montine TJ, Shi M, Zhang J. Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion. Journal of Proteome Research. 9: 2610-8. PMID 20337498 DOI: 10.1021/Pr100054V  0.593
2010 Montine TJ, Sonnen JA, Milne G, Baker LD, Breitner JC. Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. Plos One. 5: e9340. PMID 20174466 DOI: 10.1371/Journal.Pone.0009340  0.573
2010 Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, et al. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain : a Journal of Neurology. 133: 713-26. PMID 20157014 DOI: 10.1093/Brain/Awq008  0.387
2010 Sonnen JA, Montine KS, Quinn JF, Breitner JC, Montine TJ. Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia. Journal of Alzheimer's Disease : Jad. 19: 301-9. PMID 20061646 DOI: 10.3233/Jad-2010-1236  0.641
2010 Bekris LM, Galloway NM, Montine TJ, Schellenberg GD, Yu CE. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 409-17. PMID 19554612 DOI: 10.1002/Ajmg.B.30993  0.39
2010 Haneuse S, Larson E, Walker R, Montine T, Sonnen J. Neuropathology-based risk scoring for dementia diagnosis in the elderly. Journal of Alzheimer's Disease : Jad. 17: 875-85. PMID 19542615 DOI: 10.3233/Jad-2009-1105  0.609
2010 Tsuang D, Larson EB, Li G, Shofer JB, Montine KS, Thompson ML, Sonnen JA, Crane PK, Leverenz JB, Montine TJ. Association between lifetime cigarette smoking and lewy body accumulation. Brain Pathology (Zurich, Switzerland). 20: 412-8. PMID 19531100 DOI: 10.1111/J.1750-3639.2009.00296.X  0.641
2010 Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrometry Reviews. 29: 79-125. PMID 19358229 DOI: 10.1002/Mas.20221  0.43
2010 Craft S, Baker LD, Montine TJ, Zhang J, Watson GS, Plymate S, Tsai E, Callaghan M, Leverenz J, Gerton B, Trittschuh E. O4-08-01: Intranasal Insulin- And Biomarker-associated Improvement in Memory and Functional Status in Mild Cognitive Impairment and Alzheimer's Disease: Results of a Randomized, Double-blind, Placebo-controlled Pilot Trial Alzheimer's & Dementia. 6: e18-e18. DOI: 10.1016/J.Jalz.2010.08.054  0.369
2010 Leverenz JB, Zabetian C, Steinbart EJ, Nickel K, Rumbaugh M, Montine TJ, Bird TD. Four siblings with variable clinical and pathological characteristics of Alzheimer's and Lewy body disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.768  0.367
2010 Carter JL, Craft S, VanFossen B, Green PS, Baker LD, Wilkinson CW, Montine T, Watson GS, Bonner L, Plymate S, Tsai E, Callaghan M, Leverenz J, Gerton B, Kahn SE. O4-06-06: Modulating dietary fat and glycemic load affects CSF biomarkers and cognition in adults with MCI: The role of the Western diet in the pathophysiology of Alzheimer's disease Alzheimer's & Dementia. 6: S161-S161. DOI: 10.1016/J.Jalz.2010.05.501  0.345
2010 Montine TJ, SantaCruz K, Hemmy L, Sonnen J, Larson E. O2-05-06: What will be observed among cognitively normal older adults when common changes of dementia other than fibrillar beta-amyloid can be imaged? Alzheimer's & Dementia. 6: S108-S108. DOI: 10.1016/J.Jalz.2010.05.335  0.607
2010 Sonnen JA, Larson EB, Walker R, Haneuse S, Crane PK, Gray SL, Breitner JC, Montine TJ. O1-06-08: Non-steroidal anti-inflammatory drugs are associated with increased neuritic plaques Alzheimer's & Dementia. 6: S83-S83. DOI: 10.1016/j.jalz.2010.05.248  0.522
2010 Breitner JCS, Quinn J, Baker LD, Anau J, Crane S, Montine TJ. Does very low dose ibuprofen affect CSF levels of Aβ1-42 or tau in human volunteers at risk for Alzheimer's disease? a randomized controlled trial Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.201  0.327
2010 Christopher M, Larson EB, Montine TJ, Sonnen JA. P3-054: Hippocampal sclerosis in the population: Representative adult changes in thought study-prevalence and relationship to other common neuropathologies of aging Alzheimer's & Dementia. 6: S465-S465. DOI: 10.1016/J.Jalz.2010.05.1548  0.582
2010 Sonnen JA, Keene CD, Hevner RF, Montine TJ. Molecular Pathology: Neuropathology Essential Concepts in Molecular Pathology. 373-398. DOI: 10.1016/B978-0-12-374418-0.00028-1  0.547
2009 Montine TJ, Larson EB. Late-life dementias: does this unyielding global challenge require a broader view? Jama. 302: 2593-4. PMID 20009062 DOI: 10.1001/Jama.2009.1863  0.451
2009 Longstreth WT, Sonnen JA, Koepsell TD, Kukull WA, Larson EB, Montine TJ. Associations between microinfarcts and other macroscopic vascular findings on neuropathologic examination in 2 databases. Alzheimer Disease and Associated Disorders. 23: 291-4. PMID 19812473 DOI: 10.1097/Wad.0B013E318199Fc7A  0.616
2009 Wang LY, Larson EB, Sonnen JA, Shofer JB, McCormick W, Bowen JD, Montine TJ, Li G. Blood pressure and brain injury in older adults: findings from a community-based autopsy study. Journal of the American Geriatrics Society. 57: 1975-81. PMID 19793158 DOI: 10.1111/J.1532-5415.2009.02493.X  0.611
2009 Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, Montine TJ. Cognitive impairment and dementia in patients with Parkinson disease. Current Topics in Medicinal Chemistry. 9: 903-12. PMID 19754405 DOI: 10.2174/156802609789378218  0.404
2009 Cimino PJ, Sokal I, Leverenz J, Fukui Y, Montine TJ. DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain. The American Journal of Pathology. 175: 1622-30. PMID 19729484 DOI: 10.2353/Ajpath.2009.090443  0.698
2009 Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue. Toxicology and Applied Pharmacology. 240: 180-8. PMID 19716838 DOI: 10.1016/J.Taap.2009.06.025  0.636
2009 Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK, Craft S, Montine TJ. Neuropathology in the adult changes in thought study: a review. Journal of Alzheimer's Disease : Jad. 18: 703-11. PMID 19661627 DOI: 10.3233/Jad-2009-1180  0.661
2009 Shi M, Bradner J, Bammler TK, Eaton DL, Zhang J, Ye Z, Wilson AM, Montine TJ, Pan C, Zhang J. Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. The American Journal of Pathology. 175: 54-65. PMID 19498008 DOI: 10.2353/Ajpath.2009.081019  0.367
2009 Wang LY, Leverenz JB, Larson EB, Vavrek DA, Kukull WA, McCormick W, Bowen JD, Teri L, Montine T, Tsuang DW. Cognitive impairment in older adults without dementia: clinical and pathologic outcomes in a community-based sample. Journal of Geriatric Psychiatry and Neurology. 22: 256-65. PMID 19433862 DOI: 10.1177/0891988709335796  0.334
2009 Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE, Bekris LM, Raskind MA, Galasko DR, Montine TJ. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. Plos One. 4: e5424. PMID 19412541 DOI: 10.1371/Journal.Pone.0005424  0.39
2009 Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. Lack of cerebral bmaa in human cerebral cortex. Neurology. 72: 1360-1. PMID 19365059 DOI: 10.1212/Wnl.0B013E3181A0Fed1  0.54
2009 Sonnen JA, Larson EB, Gray SL, Wilson A, Kohama SG, Crane PK, Breitner JC, Montine TJ. Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Annals of Neurology. 65: 226-9. PMID 19259965 DOI: 10.1002/Ana.21508  0.641
2009 Shie FS, Nivison M, Hsu PC, Montine TJ. Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma. Current Medicinal Chemistry. 16: 643-51. PMID 19199928 DOI: 10.2174/092986709787458399  0.404
2009 Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ, Craft S. Different patterns of cerebral injury in dementia with or without diabetes. Archives of Neurology. 66: 315-22. PMID 19139294 DOI: 10.1001/Archneurol.2008.579  0.64
2009 Woltjer RL, Sonnen JA, Sokal I, Rung LG, Yang W, Kjerulf JD, Klingert D, Johnson C, Rhew I, Tsuang D, Crane PK, Larson EB, Montine TJ. Quantitation and mapping of cerebral detergent-insoluble proteins in the elderly. Brain Pathology (Zurich, Switzerland). 19: 365-74. PMID 18652590 DOI: 10.1111/J.1750-3639.2008.00190.X  0.65
2009 Duerson K, Woltjer RL, Mookherjee P, Leverenz JB, Montine TJ, Bird TD, Pow DV, Rauen T, Cook DG. Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients. Brain Pathology (Zurich, Switzerland). 19: 267-78. PMID 18624794 DOI: 10.1111/J.1750-3639.2008.00186.X  0.377
2009 Li G, Sonnen JA, Montine KS, Montine TJ. Treatment of latent stage Alzheimer’s disease with statins? Aging Health. 5: 29-32. DOI: 10.2217/1745509X.5.1.29  0.662
2009 Hata S, Maeda M, Nishimura M, Levey A, Chung KA, Montine T, Fagan A, Goate A, Bateman R, Holtzman DM, Nakaya T, Gandy S, Suzuki T. P2-190: p3-Alc peptides produced by covariant processing of Alcadein and APP implicate γ-secretase dysfunction in sporadic Alzheimer's disease Alzheimer's & Dementia. 5: P316-P317. DOI: 10.1016/J.Jalz.2009.04.502  0.334
2009 Peskind ER, Li GG, Millard S, Chi P, Sokal I, Yu C, Bekris L, Raskind MA, Galasko D, Montine TJ. P3-033: Age-related decline in cognitive function is associated with cerebrospinal fluid concentration of brain-derived neurotrophic factor Alzheimer's & Dementia. 5: P349-P350. DOI: 10.1016/J.Jalz.2009.04.1210  0.325
2008 Caudle WM, Pan S, Shi M, Quinn T, Hoekstra J, Beyer RP, Montine TJ, Zhang J. Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease. Proteomics. Clinical Applications. 2: 1484-97. PMID 21136796 DOI: 10.1002/Prca.200800043  0.805
2008 Zhang J, Keene CD, Pan C, Montine KS, Montine TJ. Proteomics of human neurodegenerative diseases. Journal of Neuropathology and Experimental Neurology. 67: 923-32. PMID 18800015 DOI: 10.1097/Nen.0B013E318187A832  0.39
2008 Cole B, Montine TJ, True L, Sonnen J. 70-year-old man with enlarged pineal gland. Brain Pathology (Zurich, Switzerland). 18: 602-4. PMID 18782174 DOI: 10.1111/J.1750-3639.2008.00210.X  0.535
2008 Cimino PJ, Keene CD, Breyer RM, Montine KS, Montine TJ. Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Current Medicinal Chemistry. 15: 1863-9. PMID 18691044 DOI: 10.2174/092986708785132915  0.665
2008 Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JC, Montine TJ. Biomarkers for cognitive impairment and dementia in elderly people. The Lancet. Neurology. 7: 704-14. PMID 18635019 DOI: 10.1016/S1474-4422(08)70162-5  0.648
2008 Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, ... Montine T, et al. A novel human disease with abnormal prion protein sensitive to protease. Annals of Neurology. 63: 697-708. PMID 18571782 DOI: 10.1002/Ana.21420  0.583
2008 Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radical Biology & Medicine. 45: 219-30. PMID 18482592 DOI: 10.1016/J.Freeradbiomed.2008.04.022  0.674
2008 Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. American Journal of Clinical Pathology. 129: 526-9. PMID 18343778 DOI: 10.1309/W01Y0B808Emeh12L  0.443
2008 Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathology (Zurich, Switzerland). 18: 220-4. PMID 18241240 DOI: 10.1111/J.1750-3639.2007.00117.X  0.346
2008 Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Jung HO, Gao J, Zhang J, Montine T. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform Journal of Proteome Research. 7: 720-730. PMID 18186601 DOI: 10.1021/Pr700630X  0.338
2008 Wilmot B, McWeeney SK, Nixon RR, Montine TJ, Laut J, Harrington CA, Kaye JA, Kramer PL. Translational gene mapping of cognitive decline. Neurobiology of Aging. 29: 524-41. PMID 17174450 DOI: 10.1016/J.Neurobiolaging.2006.11.008  0.368
2008 Larson EB, Crane P, McCurry SM, Bowen JD, McCormick WC, Teri L, Montine TJ, Craft S, Sonnen JA, Cholerton BA, Breitner JC. P4-034: Seattle adult changes in thought (ACT) study: A population-based “living laboratory” to study dementia and aging Alzheimer's & Dementia. 4: T677-T678. DOI: 10.1016/J.Jalz.2008.05.2098  0.602
2008 Cook DG, Woltjer RL, Mookherjee P, Leverenz JB, Montine TJ, Watson GS. P3-391: Detergent-insoluble glutamate transporters accumulate in both prodromal dementia and late stage Alzheimer's disease Alzheimer's & Dementia. 4: T636-T636. DOI: 10.1016/J.Jalz.2008.05.1961  0.359
2008 Sonnen JA, Li G, Shofer JB, Crane PK, Haneuse S, Tsuang DW, Leverenz J, Breitner J, Larson EB, Montine TJ. P2-114: Higher systolic blood pressure was associated with increased risk for cortical and subcortical microinfarcts and atherosclerosis of the Circle of willis at autopsy, while higher diastolic blood pressure was only associated with atherosclerosis Alzheimer's & Dementia. 4: T404-T405. DOI: 10.1016/J.Jalz.2008.05.1188  0.561
2007 Picklo MJ, Montine TJ. Mitochondrial effects of lipid-derived neurotoxins. Journal of Alzheimer's Disease : Jad. 12: 185-93. PMID 17917163 DOI: 10.3233/Jad-2007-12209  0.345
2007 Montine TJ, Quinn J, Kaye J, Morrow JD. F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. Journal of Molecular Neuroscience : Mn. 33: 114-9. PMID 17901555 DOI: 10.1007/S12031-007-0044-1  0.429
2007 Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Annals of Neurology. 62: 406-13. PMID 17879383 DOI: 10.1002/Ana.21208  0.651
2007 Li G, Larson EB, Sonnen JA, Shofer JB, Petrie EC, Schantz A, Peskind ER, Raskind MA, Breitner JC, Montine TJ. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology. 69: 878-85. PMID 17724290 DOI: 10.1212/01.Wnl.0000277657.95487.1C  0.649
2007 Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, Kaye JA, Raskind MA, Zhang J, Peskind ER, Montine TJ. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology. 69: 631-9. PMID 17698783 DOI: 10.1212/01.wnl.0000267428.62582.aa  0.37
2007 Sonnen JA, Keene CD, Montine KS, Li G, Peskind ER, Zhang J, Montine TJ. Biomarkers for Alzheimer's disease. Expert Review of Neurotherapeutics. 7: 1021-8. PMID 17678497 DOI: 10.3233/Jad-2005-8401  0.678
2007 Yang W, Woltjer RL, Sokal I, Pan C, Wang Y, Brodey M, Peskind ER, Leverenz JB, Zhang J, Perl DP, Galasko DR, Montine TJ. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. The American Journal of Pathology. 171: 993-1002. PMID 17675576 DOI: 10.2353/Ajpath.2007.070015  0.469
2007 Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, ... ... Montine TJ, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica. 114: 221-9. PMID 17653732 DOI: 10.1007/S00401-007-0261-2  0.431
2007 Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, Bird TD, Montine TJ. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology. 68: 2093-8. PMID 17562830 DOI: 10.1212/01.Wnl.0000264504.14301.F5  0.53
2007 Leverenz JB, Umar I, Wang Q, Montine TJ, McMillan PJ, Tsuang DW, Jin J, Pan C, Shin J, Zhu D, Zhang J. Proteomic identification of novel proteins in cortical lewy bodies. Brain Pathology (Zurich, Switzerland). 17: 139-45. PMID 17388944 DOI: 10.1111/J.1750-3639.2007.00048.X  0.375
2007 Allen CT, Sonnen J, Leslie MJ, Kidoguchi L, Harris C, Gambetti P, Montine TJ. Washington statewide pathology surveillance for prion disease. Annals of Neurology. 61: 371-2. PMID 17358023 DOI: 10.1002/Ana.21096  0.613
2007 Zhang J, Montine TJ. Proteomic discovery of CSF biomarkers for Alzheimer's disease. Annals of Neurology. 61: 497; author reply 49. PMID 17358005 DOI: 10.1002/Ana.21109  0.442
2007 Pan S, Zhu D, Quinn JF, Peskind ER, Montine TJ, Lin B, Goodlett DR, Taylor G, Eng J, Zhang J. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics. 7: 469-73. PMID 17211832 DOI: 10.1002/Pmic.200600756  0.352
2007 Jin J, Shie FS, Liu J, Wang Y, Davis J, Schantz AM, Montine KS, Montine TJ, Zhang J. Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated alpha-synuclein. Journal of Neuroinflammation. 4: 2. PMID 17204153 DOI: 10.1186/1742-2094-4-2  0.345
2007 House MJ, St Pierre TG, Kowdley KV, Montine T, Connor J, Beard J, Berger J, Siddaiah N, Shankland E, Jin LW. Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients. Magnetic Resonance in Medicine. 57: 172-80. PMID 17191232 DOI: 10.1002/Mrm.21118  0.329
2007 Woltjer RL, McMahan W, Milatovic D, Kjerulf JD, Shie FS, Rung LG, Montine KS, Montine TJ. Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment. Neurobiology of Disease. 25: 427-37. PMID 17141508 DOI: 10.1016/J.Nbd.2006.10.003  0.34
2007 Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiology of Aging. 28: 213-25. PMID 16448723 DOI: 10.1016/J.Neurobiolaging.2005.12.014  0.302
2007 Sonnen JA, Leverenz JB, Crane PK, Larson EB, Montine TJ. Cognitive impairment and dementia due to Alzheimer disease and cerebrovascular pathology in autopsied ACT study patients Journal of Neuropathology and Experimental Neurology. 66: 433. DOI: 10.1097/01.Jnen.0000268867.58526.1F  0.662
2007 Sonnen JA, Leverenz JB, Crane PK, Larson EB, Montine TJ. Cognitive impairment and dementia due to Alzheimer disease and cerebrovascular pathology in autopsied ACT study patients The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A72-C  0.662
2007 Montine TJ, Li G, Sonnen J, Peskind E, Leverenz J, Haneuse S, Crane P, Breitner J, Larson E. O2-04-03: Structural bases of dementia in a typical U.S. urban and suburban population and their association with statin use Alzheimer's & Dementia. 3: S193-S193. DOI: 10.1016/J.Jalz.2007.04.298  0.586
2006 Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. Journal of Alzheimer's Disease : Jad. 10: 399-406. PMID 17183151 DOI: 10.3233/Jad-2006-10408  0.409
2006 Tsuang D, Simpson K, Larson EB, Peskind E, Kukull W, Bowen JB, McCormick W, Teri L, Montine T, Thompson ML, Leverenz JB. Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 19: 195-201. PMID 17085757 DOI: 10.1177/0891988706292755  0.324
2006 Dodson SE, Gearing M, Lippa CF, Montine TJ, Levey AI, Lah JJ. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 65: 866-72. PMID 16957580 DOI: 10.1097/01.Jnen.0000228205.19915.20  0.308
2006 Maezawa I, Zaja-Milatovic S, Milatovic D, Stephen C, Sokal I, Maeda N, Montine TJ, Montine KS. Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity. Journal of Neuroinflammation. 3: 21. PMID 16934151 DOI: 10.1186/1742-2094-3-21  0.627
2006 Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, ... ... Montine TJ, et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. Journal of Alzheimer's Disease : Jad. 9: 293-348. PMID 16914840 DOI: 10.3233/Jad-2006-9309  0.426
2006 Tsuang DW, Riekse RG, Purganan KM, David AC, Montine TJ, Schellenberg GD, Steinbart EJ, Petrie EC, Bird TD, Leverenz JB. Lewy body pathology in late-onset familial Alzheimer's disease: a clinicopathological case series. Journal of Alzheimer's Disease : Jad. 9: 235-42. PMID 16914833 DOI: 10.3233/Jad-2006-9302  0.367
2006 Boutte AM, Woltjer RL, Zimmerman LJ, Stamer SL, Montine KS, Manno MV, Cimino PJ, Liebler DC, Montine TJ. Selectively increased oxidative modifications mapped to detergent-insoluble forms of Abeta and beta-III tubulin in Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 1473-83. PMID 16816122 DOI: 10.1096/Fj.06-5920Com  0.806
2006 Montine TJ, Woltjer RL, Pan C, Montine KS, Zhang J. Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 336-43. PMID 16815217 DOI: 10.1016/J.Nurx.2006.05.002  0.426
2006 Xu J, Chen J, Peskind ER, Jin J, Eng J, Pan C, Montine TJ, Goodlett DR, Zhang J. Characterization of proteome of human cerebrospinal fluid. International Review of Neurobiology. 73: 29-98. PMID 16737901 DOI: 10.1016/S0074-7742(06)73002-1  0.381
2006 Maezawa I, Maeda N, Montine TJ, Montine KS. Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice. Journal of Neuroinflammation. 3: 10. PMID 16603079 DOI: 10.1186/1742-2094-3-10  0.641
2006 Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, Raskind MA, Schellenberg GD, Bird TD, Tsuang D. Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype. Archives of Neurology. 63: 370-6. PMID 16533963 DOI: 10.1001/Archneur.63.3.370  0.397
2006 Maezawa I, Nivison M, Montine KS, Maeda N, Montine TJ. Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 797-9. PMID 16481366 DOI: 10.1096/Fj.05-5423Fje  0.641
2006 Burke BT, Latimer CS, Keene DC, Montine TJ, Sonnen J, McCormick W, Bowen JD, McCurry SM, Larson EB, Crane PK. P4-333: AUTOPSY FINDINGS OF CEREBRAL β-AMYLOIDOSIS, TAUOPATHY, AND NEURODEGENERATION (A, T AND N) IN A COMMUNITY-BASED SAMPLE: IMPLICATIONS FOR DEMENTIA MITIGATION STRATEGIES Alzheimer's & Dementia. 14: P1593-P1595. DOI: 10.1016/J.Jalz.2018.07.156  0.588
2006 White LR, Edland SD, Hemmy LS, Flanagan ME, Liu C, Feng J, Himmer EK, Montine TJ. P2-067: WHAT WOULD BE THE LIKELY IMPACT OF AN INTERVENTION THAT SUCCESSFULLY PREVENTED NEOCORTICAL ACCUMULATION OF NEURITIC AMYLOID PLAQUES AND A HIGH BRAAK STAGE? THOUGHT EXPERIMENTS USING DATA FROM THE NUN STUDY (NS) AND THE HONOLULU-ASIA AGING STUDY Alzheimer's & Dementia. 14: P692-P692. DOI: 10.1016/J.Jalz.2018.06.752  0.678
2006 White LR, Hemmy LS, Flanagan ME, Liu C, Feng J, Himmer EK, Montine TJ, Edland SD. P3-064: COGNITIVE DECLINE TRAJECTORIES IN AUTOPSIED DEMENTIA PARTICIPANTS OF THE NUN STUDY (NS) AND THE HONOLULU-ASIA AGING STUDY (HAAS): RELATIONSHIPS TO AGE, PREMORBID COGNITIVE TEST SCORES, EDUCATION, APOE4, AND NEUROPATHOLOGIC BURDEN Alzheimer's & Dementia. 14: P1089-P1089. DOI: 10.1016/J.Jalz.2018.06.1420  0.681
2006 White LR, Hemmy LS, Flanagan ME, Kawas CH, Corrada MM, Edland SD, Montine TJ. P1-111: RESISTANCE, RESERVE, AND RESILIENCE: SYSTEMS THAT DEFEND AGAINST AGE-RELATED COGNITIVE DECLINE-OBSERVATIONS FROM THE HONOLULU-ASIA AGING STUDY (HAAS) Alzheimer's & Dementia. 14: P313-P314. DOI: 10.1016/J.Jalz.2018.06.114  0.66
2006 Latimer CS, Shively CA, Keene D, Jorgensen MJ, Andrews RN, Register TC, Montine TJ, Wilson A, Neth BJ, Mintz A, Maldjian J, Whitlow CT, Kaplan JR, Craft S. P1-105: A NON-HUMAN PRIMATE MODEL OF EARLY ALZHEIMER'S DISEASE PATHOLOGIC CHANGE Alzheimer's & Dementia. 14: P311-P312. DOI: 10.1016/J.Jalz.2018.06.108  0.375
2006 Montine KS, Maezawa I, Nivison M, Maeda N, Montine TJ. P1-010: Apolipoprotein E isoform-specific modulation of innate immune response neurotoxicity in a targeted replacement APOE mouse model Alzheimer's & Dementia. 2: S97-S97. DOI: 10.1016/J.Jalz.2006.05.385  0.605
2006 Leverenz JB, Larson EB, Vavrek D, Peskind ER, Bowen JD, McCormick WC, Teri L, Kukull WA, Montine TJ, Tsuang DW. O1-04-07: ″Amygdala predominant″ Lewy body disease: A subtype of Alzheimer's disease with a more aggressive clinical course Alzheimer's & Dementia. 2: S16-S17. DOI: 10.1016/J.Jalz.2006.05.251  0.355
2006 Kukull WA, Dickson DW, Montine TJ, Ramos EM, Zhang Z, Koepsell TD. P3-190: Lewy Body (LB) pathology and clinical diagnoses in the National Alzheimer's Coordinating Center (NACC) database Alzheimer's & Dementia. 2: S430-S431. DOI: 10.1016/J.Jalz.2006.05.1458  0.336
2006 Montine TJ, Li G, Sonnen J, Peskind E, Leverenz J, Haneuse S, Crane P, Breitner J, Larson E. O2-04-03 Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.131  0.536
2006 Wang LY, Vavrek DA, Bowen JD, McCormick WC, Teri L, Montine TJ, Larson EB, Leverenz JB, Tsuang DW. P2-212: Subjective cognitive impairment without dementia: Clinical and pathological outcomes in a community-based sample Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1051  0.303
2006 Keene C, Sonnen J, Montine T. Anatomic and histologic analysis of human fetal neural transplant survival and connectivity in two patients with Huntington's disease Experimental Neurology. 198: 573. DOI: 10.1016/J.Expneurol.2006.02.054  0.547
2005 Zhang J, Goodlett DR, Montine TJ. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. Journal of Alzheimer's Disease : Jad. 8: 377-86. PMID 16556969 DOI: 10.3233/Jad-2005-8407  0.437
2005 Montine TJ, Quinn JF, Montine KS, Kaye JA, Breitner JC. Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 8: 359-67. PMID 16556967 DOI: 10.3233/Jad-2005-8405  0.424
2005 Liang X, Wang Q, Hand T, Wu L, Breyer RM, Montine TJ, Andreasson K. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10180-7. PMID 16267225 DOI: 10.1523/Jneurosci.3591-05.2005  0.405
2005 Milatovic D, VanRollins M, Li K, Montine KS, Montine TJ. Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 827: 88-93. PMID 16260380 DOI: 10.1016/J.Jchromb.2005.03.037  0.312
2005 Fishel MA, Watson GS, Montine TJ, Wang Q, Green PS, Kulstad JJ, Cook DG, Peskind ER, Baker LD, Goldgaber D, Nie W, Asthana S, Plymate SR, Schwartz MW, Craft S. Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Archives of Neurology. 62: 1539-44. PMID 16216936 DOI: 10.1001/Archneur.62.10.Noc50112  0.344
2005 Montine TJ, Li K, Perl DP, Galasko D. Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology. 65: 768-9. PMID 16157919 DOI: 10.1212/01.Wnl.0000174523.62022.52  0.389
2005 Boutté AM, Neely MD, Bird TD, Montine KS, Montine TJ. Diminished taxol/GTP-stimulated tubulin polymerization in diseased region of brain from patients with late-onset or inherited Alzheimer's disease or frontotemporal dementia with parkinsonism linked to chromosome-17 but not individuals with mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 8: 1-6. PMID 16155344 DOI: 10.3233/Jad-2005-8101  0.431
2005 Woltjer RL, Cimino PJ, Boutté AM, Schantz AM, Montine KS, Larson EB, Bird T, Quinn JF, Zhang J, Montine TJ. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1923-5. PMID 16129700 DOI: 10.1096/Fj.05-4263Fje  0.691
2005 Zagol-Ikapitte I, Masterson TS, Amarnath V, Montine TJ, Andreasson KI, Boutaud O, Oates JA. Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity. Journal of Neurochemistry. 94: 1140-5. PMID 15992375 DOI: 10.1111/J.1471-4159.2005.03264.X  0.4
2005 Shie FS, Montine KS, Breyer RM, Montine TJ. Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neurons. Brain Pathology (Zurich, Switzerland). 15: 134-8. PMID 15912885 DOI: 10.1111/J.1750-3639.2005.Tb00509.X  0.344
2005 Woltjer RL, Nghiem W, Maezawa I, Milatovic D, Vaisar T, Montine KS, Montine TJ. Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. Journal of Neurochemistry. 93: 1047-56. PMID 15857408 DOI: 10.1111/J.1471-4159.2005.03109.X  0.657
2005 Montine TJ, Morrow JD. Fatty acid oxidation in the pathogenesis of Alzheimer's disease. The American Journal of Pathology. 166: 1283-9. PMID 15855630 DOI: 10.1016/S0002-9440(10)62347-4  0.391
2005 Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ. Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. Journal of Alzheimer's Disease : Jad. 7: 125-33; discussion 1. PMID 15851850 DOI: 10.3233/Jad-2005-7205  0.45
2005 Shie FS, Breyer RM, Montine TJ. Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity. The American Journal of Pathology. 166: 1163-72. PMID 15793296 DOI: 10.1016/S0002-9440(10)62336-X  0.366
2005 Neely MD, Boutte A, Milatovic D, Montine TJ. Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Research. 1037: 90-8. PMID 15777756 DOI: 10.1016/J.Brainres.2004.12.027  0.717
2005 Wang Q, Woltjer RL, Cimino PJ, Pan C, Montine KS, Zhang J, Montine TJ. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 869-71. PMID 15746184 DOI: 10.1096/Fj.04-3210Fje  0.692
2005 Montine TJ, Montine KS, McMahan W, Markesbery WR, Quinn JF, Morrow JD. F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxidants & Redox Signaling. 7: 269-75. PMID 15650414 DOI: 10.1089/Ars.2005.7.269  0.412
2005 Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid. Neurobiology of Aging. 26: 207-27. PMID 15582749 DOI: 10.1016/J.Neurobiolaging.2004.03.012  0.379
2004 Maezawa I, Jin LW, Woltjer RL, Maeda N, Martin GM, Montine TJ, Montine KS. Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. Journal of Neurochemistry. 91: 1312-21. PMID 15584908 DOI: 10.1111/J.1471-4159.2004.02818.X  0.68
2004 Zhou Y, Shie FS, Piccardo P, Montine TJ, Zhang J. Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience. 128: 281-91. PMID 15350641 DOI: 10.1016/J.Neuroscience.2004.06.048  0.385
2004 Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, et al. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Journal of Neurochemistry. 90: 1011-8. PMID 15287908 DOI: 10.1111/J.1471-4159.2004.02532.X  0.389
2004 Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J. Analysis of alpha-synuclein-associated proteins by quantitative proteomics. The Journal of Biological Chemistry. 279: 39155-64. PMID 15234983 DOI: 10.1074/Jbc.M405456200  0.339
2004 Shie FS, Neely MD, Maezawa I, Wu H, Olson SJ, Jürgens G, Montine KS, Montine TJ. Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. The American Journal of Pathology. 164: 1173-81. PMID 15039206 DOI: 10.1016/S0002-9440(10)63205-1  0.628
2004 Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJ, Morrow JD, Montine TJ. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chemistry and Physics of Lipids. 128: 117-24. PMID 15037157 DOI: 10.1016/J.Chemphyslip.2003.10.010  0.498
2004 Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 6: 93-7. PMID 15004331 DOI: 10.3233/Jad-2004-6110  0.383
2004 Quinn J, Kaye J, Montine T, Stackman R. Phytochemicals in Alzheimer Disease: The Development of Clinical Trials Archives of Physiology and Biochemistry. 42: 64-73. DOI: 10.1080/138802090893531  0.339
2004 Davies SS, Bernoud-Hubac N, Olsen S, Montine TJ, Jackson Roberts L. P4-229 Highly reactive γ-ketoaldehydes in Alzheimer's disease Neurobiology of Aging. 25: S540. DOI: 10.1016/S0197-4580(04)81787-1  0.383
2003 Woltjer RL, Maezawa I, Ou JJ, Montine KS, Montine TJ. Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity. Journal of Alzheimer's Disease : Jad. 5: 467-76. PMID 14757937 DOI: 10.3233/Jad-2003-5607  0.711
2003 Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ, Montine TJ. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. Journal of Neurochemistry. 87: 1518-26. PMID 14713307 DOI: 10.1046/J.1471-4159.2003.02120.X  0.304
2003 Pulliam JF, Jennings CD, Kryscio RJ, Davis DG, Wilson D, Montine TJ, Schmitt FA, Markesbery WR. Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 119: 48-53. PMID 12707938 DOI: 10.1002/Ajmg.B.10069  0.41
2003 Bassett CN, Montine TJ. Lipoproteins and lipid peroxidation in Alzheimer's disease. The Journal of Nutrition, Health & Aging. 7: 24-9. PMID 12679837  0.82
2003 Sidell KR, Montine KS, Picklo MJ, Olsen SJ, Amarnath V, Montine TJ. Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. Journal of Neuropathology and Experimental Neurology. 62: 146-53. PMID 12578224 DOI: 10.1093/Jnen/62.2.146  0.797
2003 Montine TJ, Montine KS, Reich EE, Terry ES, Porter NA, Morrow JD. Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes. Biochemical Pharmacology. 65: 611-7. PMID 12566089 DOI: 10.1016/S0006-2952(02)01607-6  0.629
2003 Zhang J, Fitsanakis VA, Gu G, Jing D, Ao M, Amarnath V, Montine TJ. Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. Journal of Neurochemistry. 84: 336-46. PMID 12558996 DOI: 10.1046/J.1471-4159.2003.01525.X  0.713
2003 Montine KS, Quinn JF, Montine TJ. Overview: Membrane lipid peroxidation Advances in Cell Aging and Gerontology. 12: 11-26. DOI: 10.1016/S1566-3124(03)12002-0  0.346
2002 Montine KS, Sidell KR, Zhang J, Montine TJ. Dopamine thioethers: formation in brain and neurotoxicity. Neurotoxicity Research. 4: 663-669. PMID 12709304 DOI: 10.1080/1029842021000045435  0.781
2002 Reich EE, Montine TJ, Morrow JD. Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Advances in Experimental Medicine and Biology. 507: 519-24. PMID 12664634 DOI: 10.1007/978-1-4615-0193-0_79  0.577
2002 Fitsanakis VA, Amarnath V, Moore JT, Montine KS, Zhang J, Montine TJ. Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides. Free Radical Biology & Medicine. 33: 1714-23. PMID 12488139 DOI: 10.1016/S0891-5849(02)01169-3  0.701
2002 Picklo MJ, Montine TJ, Amarnath V, Neely MD. Carbonyl toxicology and Alzheimer's disease. Toxicology and Applied Pharmacology. 184: 187-97. PMID 12460747 DOI: 10.1006/Taap.2002.9506  0.435
2002 Neely MD, Montine TJ. CSF lipoproteins and Alzheimer's disease. The Journal of Nutrition, Health & Aging. 6: 383-91. PMID 12459889  0.319
2002 Boutaud O, Ou JJ, Chaurand P, Caprioli RM, Montine TJ, Oates JA. Prostaglandin H2 (PGH2) accelerates formation of amyloid beta1-42 oligomers. Journal of Neurochemistry. 82: 1003-6. PMID 12358806 DOI: 10.1046/J.1471-4159.2002.01064.X  0.582
2002 Bassett CN, Swift LL, Montine KS, Markesbery WR, Montine TJ. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration. Journal of Alzheimer's Disease : Jad. 4: 19-30. PMID 12214015 DOI: 10.3233/Jad-2002-4103  0.809
2002 Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ, Kaye JA, Morrow JD. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Annals of Neurology. 52: 175-9. PMID 12210787 DOI: 10.1002/Ana.10272  0.32
2002 Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biology & Medicine. 33: 620-6. PMID 12208348 DOI: 10.1016/S0891-5849(02)00807-9  0.438
2002 Gu G, Reyes PE, Golden GT, Woltjer RL, Hulette C, Montine TJ, Zhang J. Mitochondrial DNA deletions/rearrangements in parkinson disease and related neurodegenerative disorders. Journal of Neuropathology and Experimental Neurology. 61: 634-9. PMID 12125742 DOI: 10.1093/Jnen/61.7.634  0.368
2002 Ou JJ, Zhang Y, Montine TJ. In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases. Experimental Neurology. 175: 363-9. PMID 12061866 DOI: 10.1006/Exnr.2002.7923  0.575
2002 Zhang J, Montine TJ, Smith MA, Siedlak SL, Gu G, Robertson D, Perry G. The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism & Related Disorders. 8: 165-70. PMID 12039426 DOI: 10.1016/S1353-8020(01)00041-4  0.363
2002 Montine KS, Montine TJ, Morrow JD, Frei B, Milatovic D, Eckenstein F, Quinn JF. Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment. Brain Research. 930: 75-82. PMID 11879798 DOI: 10.1016/S0006-8993(01)03409-6  0.374
2002 Castellani RJ, Perry G, Siedlak SL, Nunomura A, Shimohama S, Zhang J, Montine T, Sayre LM, Smith MA. Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neuroscience Letters. 319: 25-8. PMID 11814645 DOI: 10.1016/S0304-3940(01)02514-9  0.562
2001 Sidell KR, Amamath V, Montine TJ. Dopamine thioethers in neurodegeneration. Current Topics in Medicinal Chemistry. 1: 519-27. PMID 11895128  0.788
2001 Reich EE, Markesbery WR, Roberts LJ, Swift LL, Morrow JD, Montine TJ. Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Advances in Experimental Medicine and Biology. 500: 253-6. PMID 11764949 DOI: 10.1007/978-1-4615-0667-6_39  0.652
2001 Sidell KR, Olson SJ, Ou JJ, Zhang Y, Amarnath V, Montine TJ. Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo. Journal of Neurochemistry. 79: 510-21. PMID 11701754 DOI: 10.1046/J.1471-4159.2001.00586.X  0.778
2001 Picklo MJ, Olson SJ, Hayes JD, Markesbery WR, Montine TJ. Elevation of AKR7A2 (succinic semialdehyde reductase) in neurodegenerative disease. Brain Research. 916: 229-38. PMID 11597610 DOI: 10.1016/S0006-8993(01)02897-9  0.386
2001 Reich EE, Montine KS, Gross MD, Roberts LJ, Swift LL, Morrow JD, Montine TJ. Interactions between apolipoprotein E gene and dietary alpha-tocopherol influence cerebral oxidative damage in aged mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 5993-9. PMID 11487622  0.582
2001 Picklo MJ, Olson SJ, Markesbery WR, Montine TJ. Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 60: 686-95. PMID 11444797 DOI: 10.1093/Jnen/60.7.686  0.407
2001 Bernoud-Hubac N, Davies SS, Boutaud O, Montine TJ, Roberts LJ. Formation of highly reactive gamma-ketoaldehydes (neuroketals) as products of the neuroprostane pathway. The Journal of Biological Chemistry. 276: 30964-70. PMID 11413140 DOI: 10.1074/Jbc.M103768200  0.335
2001 Picklo MJ, Montine TJ. Acrolein inhibits respiration in isolated brain mitochondria. Biochimica Et Biophysica Acta. 1535: 145-52. PMID 11342003 DOI: 10.1016/S0925-4439(00)00093-4  0.359
2001 Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, Quinn JF. Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls. Archives of Pathology & Laboratory Medicine. 125: 510-2. PMID 11260625 DOI: 10.1043/0003-9985(2001)125<0510:Cfataf>2.0.Co;2  0.376
2001 Reich EE, Markesbery WR, Roberts LJ, Swift LL, Morrow JD, Montine TJ. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. The American Journal of Pathology. 158: 293-7. PMID 11141503 DOI: 10.1016/S0002-9440(10)63968-5  0.646
2001 Reich EE, Montine KS, Gross MD, Roberts LJ, Swift LL, Morrow JD, Montine TJ. Interactions between Apolipoprotein E Gene and Dietary α-Tocopherol Influence Cerebral Oxidative Damage in Aged Mice The Journal of Neuroscience. 21: 5993-5999. DOI: 10.1523/Jneurosci.21-16-05993.2001  0.62
2000 Montine TJ, Amarnath V, Picklo MJ, Sidell KR, Zhang J, Graham DG. Dopamine mercapturate can augment dopaminergic neurodegeneration. Drug Metabolism Reviews. 32: 363-76. PMID 11139134 DOI: 10.1081/Dmr-100102339  0.782
2000 Neely MD, Swift LL, Montine TJ. Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules. Lipids. 35: 1249-57. PMID 11132184 DOI: 10.1007/S11745-000-0641-8  0.367
2000 Montine TJ, Shinobu L, Montine KS, Roberts LJ, Kowall NW, Beal MF, Morrow JD. No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls. Annals of Neurology. 48: 950. PMID 11117557 DOI: 10.1002/1531-8249(200012)48:6<950::Aid-Ana23>3.0.Co;2-F  0.343
2000 Neely MD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, Montine KS, Amaranth V, Montine TJ. Congeners of N(alpha)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radical Biology & Medicine. 29: 1028-36. PMID 11084291 DOI: 10.1016/S0891-5849(00)00411-1  0.605
2000 Bassett CN, Montine KS, Neely MD, Swift LL, Montine TJ. Cerebrospinal fluid lipoproteins in Alzheimer's disease. Microscopy Research and Technique. 50: 282-6. PMID 10936881 DOI: 10.1002/1097-0029(20000815)50:4<282::Aid-Jemt6>3.0.Co;2-T  0.813
2000 Zhang J, Graham DG, Montine TJ, Ho YS. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. Journal of Neuropathology and Experimental Neurology. 59: 53-61. PMID 10744035 DOI: 10.1093/Jnen/59.1.53  0.34
2000 Reich EE, Zackert WE, Brame CJ, Chen Y, Roberts LJ, Hachey DL, Montine TJ, Morrow JD. Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry. 39: 2376-83. PMID 10694406 DOI: 10.1021/Bi992000L  0.617
2000 Zhang J, Kravtsov V, Amarnath V, Picklo MJ, Graham DG, Montine TJ. Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease. Journal of Neurochemistry. 74: 970-8. PMID 10693927 DOI: 10.1046/J.1471-4159.2000.0740970.X  0.35
1999 Bassett CN, Neely MD, Sidell KR, Markesbery WR, Swift LL, Montine TJ. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids. 34: 1273-80. PMID 10652986 DOI: 10.1007/S11745-999-0478-1  0.796
1999 Valyi-Nagy T, Sidell KR, Marnett LJ, Roberts LJ, Dermody TS, Morrow JD, Montine TJ. Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis. Journal of Neuropathology and Experimental Neurology. 58: 1269-75. PMID 10604752 DOI: 10.1097/00005072-199912000-00008  0.796
1999 Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ, Morrow JD. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 53: 1495-8. PMID 10534257 DOI: 10.1212/Wnl.53.7.1495  0.806
1999 Montine TJ, Markesbery WR, Zackert W, Sanchez SC, Roberts LJ, Morrow JD. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. The American Journal of Pathology. 155: 863-8. PMID 10487843 DOI: 10.1016/S0002-9440(10)65185-1  0.425
1999 Montine TJ, Montine KS, Olson SJ, Graham DG, Roberts LJ, Morrow JD, Linton MF, Fazio S, Swift LL. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice. Experimental Neurology. 158: 234-41. PMID 10448437 DOI: 10.1006/Exnr.1999.7067  0.359
1999 Neely MD, Sidell KR, Graham DG, Montine TJ. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. Journal of Neurochemistry. 72: 2323-33. PMID 10349841 DOI: 10.1046/J.1471-4159.1999.0722323.X  0.81
1999 Zhang J, Perry G, Smith MA, Robertson D, Olson SJ, Graham DG, Montine TJ. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. The American Journal of Pathology. 154: 1423-9. PMID 10329595 DOI: 10.1016/S0002-9440(10)65396-5  0.367
1999 Montine TJ, Beal MF, Robertson D, Cudkowicz ME, Biaggioni I, O'Donnell H, Zackert WE, Roberts LJ, Morrow JD. Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease. Neurology. 52: 1104-5. PMID 10102447 DOI: 10.1212/Wnl.52.5.1104  0.345
1999 Picklo MJ, Amarnath V, McIntyre JO, Graham DG, Montine TJ. 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. Journal of Neurochemistry. 72: 1617-24. PMID 10098869 DOI: 10.1046/J.1471-4159.1999.721617.X  0.314
1999 Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Increased CSF F2-isoprostane concentration in probable AD. Neurology. 52: 562-5. PMID 10025788 DOI: 10.1212/Wnl.52.3.562  0.311
1999 NUNOMURA A, PERRY G, ZHANG J, MONTINE TJ, TAKEDA A, CHIBA S, SMITH MA. RNA Oxidation in Alzheimer and Parkinson Diseases Journal of Anti-Aging Medicine. 2: 227-230. DOI: 10.1089/Rej.1.1999.2.227  0.354
1999 Reich EE, Montine TJ, Morrow JD. Formation of novel D-ring and E-ring isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid Prostaglandins & Other Lipid Mediators. 59: 94. DOI: 10.1016/S0090-6980(99)90329-5  0.6
1998 Montine KS, Bassett CN, Ou JJ, Markesbery WR, Swift LL, Montine TJ. Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins. Journal of Lipid Research. 39: 2443-51. PMID 9831633  0.81
1998 Montine TJ, Markesbery WR, Morrow JD, Roberts LJ. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease. Annals of Neurology. 44: 410-3. PMID 9749613 DOI: 10.1002/Ana.410440322  0.402
1998 Zhang J, Price JO, Graham DG, Montine TJ. Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures. Biochemical and Biophysical Research Communications. 248: 812-6. PMID 9704010 DOI: 10.1006/Bbrc.1998.9044  0.315
1998 Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. Journal of Neuropathology and Experimental Neurology. 57: 415-25. PMID 9596412 DOI: 10.1097/00005072-199805000-00005  0.819
1998 Amarnath V, Valentine WM, Montine TJ, Patterson WH, Amarnath K, Bassett CN, Graham DG. Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy. Chemical Research in Toxicology. 11: 317-28. PMID 9548802 DOI: 10.1021/Tx970176N  0.761
1997 Montine TJ, Picklo MJ, Amarnath V, Whetsell WO, Graham DG. Neurotoxicity of endogenous cysteinylcatechols. Experimental Neurology. 148: 26-33. PMID 9398447 DOI: 10.1006/Exnr.1997.6662  0.303
1997 Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. Journal of Neuropathology and Experimental Neurology. 56: 866-71. PMID 9258256 DOI: 10.1097/00005072-199708000-00004  0.47
1997 Montine KS, Olson SJ, Amarnath V, Whetsell WO, Graham DG, Montine TJ. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. The American Journal of Pathology. 150: 437-43. PMID 9033259  0.327
1990 Montine TJ, Borch RF. Role of endogenous sulfur-containing nucleophiles in an in vitro model of cis-diamminedichloroplatinum(II)-induced nephrotoxicity. Biochemical Pharmacology. 39: 1751-7. PMID 2344372 DOI: 10.1016/0006-2952(90)90121-Z  0.519
1990 Borch RF, Montine TJ. Renal toxicity of antineoplastic agents. Toxicology Letters. 53: 93-6. PMID 2219193 DOI: 10.1016/0378-4274(90)90100-Z  0.523
Show low-probability matches.